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Summary 
Chitinases are enzymes that break down chitin, a homopolymer of N-
acetylglucosamine (GlcNAc) to its monomers. They are important molecules in the 
life cycle of parasitic nematodes representing important drug and vaccine targets. In 
this thesis, three genomic chitinase sequences (I, II and III) were obtained by 
characterising nine clones from a genomic library of Acanthocheilonema viteae. 
Southern blots independently confirmed the existence of three chitinase genes in A. 
viteae. The organisation of all three genomic sequences is similar, with the greatest 
difference occurring in exons encoding the serine-threonine rich domain of 
chitinases: this domain is about ten times larger in sequence III compared to I, but is 
absent in sequence II. Sequence I and III had features of regularly transcribed genes: 
start ATG, followed by an open reading frame, stop codon and polyadenylation signal. 
Sequence II lacked the first exon with start ATG. Screening of cDNA libraries from 
adult female A. viteae worms and L3 (third-stage larvae), respectively, as well as 
reverse transcriptase PCR (RT-PCR) showed transcripts in uterine microfilariae, L3 
and L4 (fourth-stage larvae) for gene I only.  
The N-terminal fragment of A. viteae chitinase was cloned into an expression vector 
and expressed in Escherichia coli. About 80% of the expressed chitinase were found 
in inclusion bodies and were purified under denaturing conditions. The soluble 
fraction was about 20% and could be purified under native conditions. Chitinase 
purified from inclusion bodies was 13-fold less active compared to soluble chitinase.  
Synthetic peptides (P1 and P2) were designed from the active site of A. viteae 
chitinase, and used in parallel with chitinase from inclusion bodies in vaccination 
experiments using the A. viteae / Meriones unguiculatus filariasis model. Vaccination 
with recombinant protein led to a 29 % significant reduction in adult worm burden in a 
single experiment. Vaccination with P1 and P2 led to an overall non significant 
reduction in adult worm burden in two independent experiments. In the P1 group, 
there was a consistent reduction (39%, p>0.05 and 45%, p<0.05) in mf load that 
attained significance only in the second experiment. In the P2 group, there was no 
reduction in mf burden in the first experiment, but a significant reduction (75%, 
p<0.05) in the second. 
These results suggest that filarial chitinases are potential targets for transmission 
blocking drugs and vaccines.  
Zusammenfassung  V 
Zusammenfassung 
Chitinasen sind Enzyme, die Chitin, ein Homopolymer des N-Acetylglucosamin 
(GlcNAc) in seine Monomere spalten. Diese sind wichtige Moleküle im Lebenszyklus 
der parasitischen Fadenwürmer, welche bedeutende Medikamenten- und 
Impfstoffziele darstellen. In der vorliegenden Arbeit wurden durch die 
Charakterisierung von 9 Klonen aus einer Genbank von Acanthocheilonema viteae 
drei genomische Chitinasesequenzen (I, II und III) gefunden. Diese Anzahl an 
Chitinasegenen wurde durch Southern-Blots bestätigt. Der Aufbau aller drei 
Sequenzen ist sehr ähnlich. Die größten Unterschiede sind in den Exons zu finden, 
welche die Serin-Threonin-reiche Domäne der Chitinasen codieren. Diese Domäne 
ist in Sequenz III ca. 10fach länger als in Sequenz I. In Sequenz II ist sie nicht 
vorhanden. Sequenz I und III hatten Eigenschaften eines regulär transkribierten 
Genes: eine Startcodon, gefolgt von einem offener Leserahmen, einem Stopcodon 
und einem Polyadenylierungssignal. Sequenz II fehlt das erste Exon mit dem 
Startcodon. Bei Durchmusterung einer cDNA-Bibliothek adulter A. viteae Würmer 
bzw. L3 Stadien, sowie durch Reverser Transkriptase-PCR (RT-PCR) wurden in den 
Mikrofilarien, L3 und  L4 Transkripte für Gen I gefunden, jedoch nicht für Gen III.  
Das N-terminale Fragment der A. viteae-Chitinase wurde in ein Expressionsplasmid 
ligiert und in E. coli exprimiert. Ungefähr 80 % der exprimierten Chitinase lagen in 
Einschluss-Körpern vor. Dieser Anteil konnte unter denaturierenden Bedingungen 
aufgereinigt werden. Der lösliche Anteil konnte unter nativen Bedigungen aufgereinigt 
werden. Die aus den Einschluss-Körpern aufgereinigte Chitinase zeigte im Vergleich 
zur löslichen Chitinase eine 13fach verminderte Aktivität. 
Vom aktiven Zentrum der Chitinase wurden Peptide synthetisiert. Diese wurden 
parallel mit Chitinase aus den Einschluss-Körpern für Vakzinierungsexperimente im 
A. viteae / Meriones unguiculatus-Filarien-Modell genutzt. Die Reduzierung der 
Wurmlast um 29 % nach einer Immunisierung mit rekombinantem Protein zeigte eine 
tendenziell schützende Kapazität des verwendeten Proteins. In zwei unabhängigen 
Experimenten konnte nach Immunisierung mit zwei synthetischen Peptiden (P1 und 
P2) eine bedeutende Reduktion der Wurmlast beobachtet werden. In der P1-Gruppe 
gab es eine gleichmäßige Reduktion der Mf-Last, die nur im zweiten Experiment 
signifikant war (39 %, p > 0,05 und 45 %, p < 0,05). In der P2-Gruppe konnte in 
einem von zwei Experimenten eine signifikante Reduktion der Mf-Last erzielt werden 
(75 %, p < 0,05). 
Zusammenfassung  V 
Diese Ergebnisse lassen vermuten, daß Filarien-Chitinasen potenzielle Ziele für 
Medikamente und Impfstoffe sind.  
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1 Introduction 
Infection with filarial parasites affect about 200 million people worldwide (Saint André 
et al., 2002). Onchocerca volvulus, the cause of onchocerciasis, is a major health 
problem in 36 endemic countries of Africa, Latin America and the Arabian Peninsula; 
it is responsible for one million visually impaired subjects, 270,000 bilaterally blind 
cases and 6.5 million subjects suffering from severe itching or dermatitis. Globally, 18 
million people are infected with the parasite, while some 120 million others are at risk 
of infection (http://www.who.int/int-fs/en/fact095.html). Lymphatic filariasis, caused by 
the parasites Brugia malayi and Wuchereria bancrofti, affects about 120 million 
people worldwide, of which 40 million are incapacitated and disfigured. It is a major 
health problem in India, Africa, South Asia and the Pacific (http://www.who.int/ 
mediacentre/fact sheets/fs102/en/). 
Chemotherapeutic treatment and vector control are two strategies used to fight 
filariasis, but none of these strategies can have a long-lasting impact in endemic 
areas (Hougard et al., 1997; Cook et al., 2001, Richards et al., 2001). Vaccination is 
a promising additional control measure, and various strategies were used to identify 
and validate preventive vaccine candidates for filariasis (Abraham et al., 2002). 
The search for chemotherapeutically and immunologically relevant target molecules 
led among others to a group of enzymatically active molecules, the chitinases. 
1.1 Structure and function of chitinases 
Chitinases (classified as EC 3.2.1.14 by the International Union of Biochemistry and 
Molecular Biology) are enzymes that break down chitin, a homopolymer of N-
acetylglucosamine (GlcNAc) to its monomers. They are ubiquitous in the plant and 
animal kingdom (Flach et al., 1992) and play important structural, physiological, 
metabolic and defensive roles (Cohen-Kupiec et al., 1998; Felse et al., 1999). 
Chitinases are glycosyl hydrolases, a family that is subdivided according to their 
hydrolysis mechanisms and amino acid sequence similarities of catalytic domains 
(Henrissat, 1999; Henrissat and Bairoch, 1993, 1996) (http://afmb.cnrs-mrs.fr/CAZY). 
Chitinases belong to class 18 and 19 of this grouping. Family 18 chitinases are 
endochitinases that cleave chitin by a retaining mechanism through which the beta-
linked polymer is cleaved to release beta anomer products. Family 19 chitinases are 
mostly found in plants, some bacteria and nematodes and cleave chitin by an 
inversion or retention mechanism (Robertus and Monzingo, 1999; Fukamizo, 2000; 
Introduction  2 
Honda et al., 2004). Family 19 class IA/I and IB/II enzymes differ in the presence 
(IA/I) or absence (IB/II) of an N-terminal chitin-binding domain. Chitinases also have 
a carbohydrate-binding module that promotes adsorption of the enzyme to insoluble 
chitin. The chitin binding domain of filarial family 18 chitinases (EC 3.2.1.14) are in 
the carbohydrate-binding module family 14, and contain six conserved cysteins that 
probably form three disulfide bridges (Henrissat and Bairoch, 1993, 1996) 
(http://afmb.cnrs-mrs.fr/CAZY/).  
 
Although the overall sequence similarity (average pair wise identity) between family 
18 chitinases is only 21% (http://www.sanger.ac.uk/Software/Pfam), their active site 
regions contain many residues that are fully or highly conserved, and their structure is 
a TIM barrel fold as typified by chitinase-1 of Coccidiodes immitis (Figure 1) (Hollis et 
al., 1998; 2000; Perakis et al., 1994; Terwischa van Scheltinga et al., 1994; van 
Aalten et al., 2001). 
 
 
Fig. 1:  Structure of chitinase-1 from Coccidiodes immitis. 
A TIM-barrel (β /α)8) structure is shown on the left, and a model showing the catalytic Glu and 
positions of substrate contact is shown on the right. Diagrams were kindly provided by Prof. Dr. W. 
Höhne, Humboldt-University of Berlin) 
In ChiB from Serratia marcescens, Tyr10, Ser93, Asp140, Asp142, Glu144, Tyr214, 
Asp215 and their corresponding subsets in other family 18 chitinases have been 
shown to be important for catalysis. The catalytically active residue is a glutamate in 
a stretch of highly conserved amino acids having the consensus DXDXE motif 
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(Watanabe et al., 1993; Bortone et al., 2002). The other residues important for 
catalysis have both mechanistic and chemical roles (Synstad et al., 2004). The 
carbohydrate binding clefts are present on the C-terminal side of the β strands in the 
(β /α)8 barrel (Fusseti et al., 2003).  
 
Chitinases have been described for the infective larval (L3) stage of A. viteae (Adam 
et al., 1996; Wu et al., 1996) and O. volvulus (Wu et al., 1996), as well as in the 
microfilarial stage of B. malayi, B. pahangi (Fuhrman et al., 1992) and in infective 
larvae (L3) and microfilariae of W. bancrofti (Raghavan et al., 1994). L3 chitinases of 
A. viteae and O. volvulus are accumulated in the glandular oesophagus of the worms 
in their insect vectors, and released when the larvae are transmitted to the hosts and 
eventually diminish following moulting from L3 to L4 (Wu et al., 1996). Micorfilaria-
specific chitinases (Fuhrman et al., 1992) could be recognised by a monoclonal 
antibody in extracts of microfilariae following several days of maturation in the 
vertebrate host as blood-borne microfilariae (Furhman et al., 1987). Interestingly, the 
appearance of these chitinases corresponds with the parasite's ability to infect the 
insect host (Fuhrman et al., 1992). To understand the possible role of these 
chitinases in the filariae, it is worth taking a brief look into the biology and 
biochemistry of the filariae relative to chitinase. 
The filariae can be divided into two groups based on their mode of embryogenesis 
and eggshell remodelling, which arises from the two distinct patterns of intrauterine 
embryonic development (Rogers et al., 1976; Ellis et al., 1978). In filarial species like 
D. immitis, O. volvulus and A. viteae, the developing embryo hatches from its 
eggshell within the maternal uterus, and is subsequently shed as a microfilaria with 
no extracuticular structures or sheath. In W. bancrofti, B. malayi, and B. pahangi, the 
eggshell is remodelled as a sheath that eventually becomes part of the microfilaria. 
Another important difference is the route of migration of filarial microfilariae in their 
arthropod hosts. B. malayi and B. pahangi microfilariae penetrate the midgut of the 
mosquito vector and enter the haemocoel, while microfilariae of D. immitis enter the 
Malpighian tubules through the lumen at the posterior end of the gut. 
The presence of chitin, the substrate of chitinases, has been biochemically 
documented in various nematode species and tissues. Chitin has been shown to be 
a component of the egg shells of many nematodes including the filariae (Brydon et 
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al., 1987). In addition, chitin has been demonstrated on the sheath of B. malayi 
microfilariae (Kaushal et al., 1984) and W. bancrofti microfilariae (Araujo et al., 1993).  
 
In view of the biology and location of filarial chitinases, microfilaria chitinases of 
Brugian and Bancroftian filariae have been proposed to have a function in ex-
sheathing the microfilaria when they are taken up in the arthropod vectors (Fuhrman 
et al., 1992). A. viteae and O. volvulus L3 chitinase are thought to have roles in 
ecdysis during post-infective development of the filariae, and in worm migration 
through the interstitial tissues of the host (Adam et al., 2001; Wu et al., 1996; 2001). 
1.2 Filarial chitinases are potential targets for interventions 
Filarial chitinases are potential targets for drug and immune interventions. Several 
observations implicate filarial chitinases to have roles in immune protection. In 
endemic areas, there are putatively immune (PIs) individuals (Elson et al., 1994; 
Turaga et al., 2000) with no current or past evidence of filarial infections. Interestingly, 
the sera of individuals putatively immune for W. bancrofti infection recognised a 43kD 
B. malayi L3 chitinase-like molecule, as opposed to the sera of microfilaremic 
individuals (Freedman et al., 1989). A monoclonal antibody that mediated microfilaria 
clearance upon transfer recognised two B. malayi microfilaria-specific chitinases 
(Canlas et al., 1984a; Canlas et al., 1984b; Southworth et al., 1996). In addition, 
Vaccination of jirds with irradiated A. viteae L3 led to 90% protection (Lucius et al., 
1991) and the sera of vaccinated rodents dominantly recognised A. viteae L3 
chitinase in blots, implicating L3 chitinase as an immunodominant antigen playing an 
important role in the immune protection of the animals (Adam et al., 1996). These 
observations suggest that filarial chitinases may play a role in protective immunity.  
Further more, immunisation of mice with O. volvulus chitinase DNA led to a 
significant reduction of 53% of worm burden following challenge infection (Harrison et 
al., 1999), experimentally confirming the relevance of filarial chitinases as vaccine 
molecules. 
An alternative approach to immunisation with recombinant proteins would be the use 
of synthetic peptides designed from the active sites of filarial chitinases. 
Immunisation with such peptides could lead to the production of neutralising 
antibodies that will inhibit enzyme activity in the parasites (da Costa et al., 1999; 
Hirota et al., 2001; Fujii et al., 2004). A major short coming is the absence of a crystal 
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structure for filarial chitinase. In the absence of a crystal structure, homology 
modelling could be used to design peptides. The highest homology between filarial 
chitinases and a chitinase with known structure is between A. viteae chitinase and 
chitinase-1 of C. immitis (Höhne, personal communication). Using homology 
modelling, a structure of the active site of filarial chitinases could be obtained with C. 
immitis chitinase as template (Figure 2) (Höhne, personal communication).  
 
 
Fig. 2: Structural model of the active sites of Acanthocheilonema viteae (light green) 
and Onchocerca volvulus (blue) chitinases. 
Non identical amino acids are shown in yellow for A. viteae and red for O. volvulus chitinase. The 
catalytic Glu is shown in green for both chitinases. Diagram was kindly provided by Prof. Dr. W. 
Höhne, Humboldt-University of Berlin. 
No direct evidence exists to show that filarial chitinases are targets for drug 
intervention. However, chitinase molecules have been shown to be associated with 
parasite transmission and moulting (Wu et al., 1996; Fuhrman et al., 1987) and so 
will represent targets for transmission blocking drugs or vaccines. So far, the most 
effective inhibitor against family 18 chitinases is allosamidin (Sakuda et al., 1987). 
Due the cost of allosamidin, it is necessary to search for new and cheaper substitute 
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inhibitors. A prerequisite to the evaluation of potential inhibitors will be the production 
of soluble homogenous chitinase. 
1.3 A. viteae as a model to investigate parasitological parameters of 
filarial diseases 
Research in filariasis is dependent on the use of laboratory animal models owing to 
the inability to measure adult parasite population in humans. The filarial parasites are 
host-specific and so the first type of model system involves the use of parasites in 
surrogate models. The Brugia spp. / BALB/c mouse system has been used as a 
chemotherapeutic (Devaney et al., 1985) and immunological (Carlow and Philipp, 
1987) model for the brugian filariasis. A similar approach with Onchocerca spp. 
involves the implantation of Onchocerca spp. in subcutaneous chambers in CBA/J or 
DBA/2J mice (Townson and Bianco, 1982; Abraham et al., 1992). These systems 
have a set back in that they rely on studies of a parasite in its non-natural host, a 
disadvantage that can be overcome by the use of full life-cycle models of the filaria 
Brugia pahangi in cats (Grenfell et al., 1991), bovine Onchocerca spp. or rodent 
filariae, like Acanthocheilonema viteae and Litomosoides carinii, in their natural hosts 
(reviewed in Abraham et al., 2002). Owing to the lack of adequate immunoreagents 
the underlying immunological mechanisms can however not be investigated in these 
model systems. The B. pahangi / cat model serves as a model for Brugia and 
Wuchereria in humans (Grenfell et al., 1991). This model system can be used to 
elucidate relationships between infection, immunity and disease states in lymphatic 
filariasis.  
A. viteae in its natural host Meriones unguiculatus serves as a model for 
onchocerciasis, the disease caused by O. volvulus. This filarial model has some 
parallels to O. volvulus in that both reside in the subcutaneous tissue of their hosts 
and are therefore in the same immunological compartment. However, they do not 
form nodules and eye lesions like O. volvulus. Further more, both parasites share an 
array of antigenic similarities as demonstrated by anti-O. volvulus monoclonal 
antibodies (Nogami et al., 1986), and a high homology in corresponding molecules 
that have so far been characterised from both parasites. In addition, cross-protection 
between species has been shown in filariasis (Storey et al., 1982; Geiger et al., 1996) 
so that vaccine candidates established in one system could be tested in others. The 
A. viteae / Meriones system allows the study of resistance to challenge infection 
following immunisation (Abraham et al., 2002). 
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In the A. viteae / jird-model, it has been shown that immunisation with irradiated A. 
viteae L3 led to 90% protection against challenge infection, while immunisation with 
excretory-secretory products (ESP) led to 70% protection (Lucius et al., 1991). 
Parallel results were also obtained using irradiated L3s in other filariasis models 
(Lange et al., 1993; Taylor et al., 1994; Johnson et al., 1998; Trees et al., 2000) and it 
could be shown in this model that immunisation with irradiated L3 could also lead to 
resistance against homologous challenge infection (Abraham et al., 2002). 
                           
Fig. 3:  Life cycle of Acanthocheilonema viteae 
L1, L2, L3 and L4 are successive larval stages. Source: Archive of the Chair of Molecular Parasitology, 
Humboldt-University, Berlin. 
1.4 Aims and objectives of the study 
The aims of this study were three-fold. Firstly, A. viteae chitinase genes had to be 
isolated and characterised. To verify the hypothesis that there are several A. viteae 
chitinase genes, a cDNA library of female worms and L3, as well as cDNA from 
uterine microfilariae were screened for chitinase genes. Chitinase genes were 
investigated at the genomic level for copy number and gene organisation. 
The second aim was the production of homogenous and enzymatically active A. 
viteae chitinase for use in inhibitor and structural studies. 
The third aim was to evaluate the protective potentials of A. viteae chitinase and its 
synthetic peptides in immunisation studies. Since A. viteae chitinase activity has 
been demonstrated in two life stages of the filaria (microfilariae and infective larvae) 
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which could be targets for transmission blocking vaccines, another specific aim of this 
study was to design synthetic peptides from three-dimensional model of A. viteae 
chitinase for use in vaccination, in parallel with A. viteae N-terminal glycosyl 
hydrolase domain of chitinase. 
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2 Results 
2.1 Characterisation of A. viteae chitinase genes 
2.1.1 Determination of the gene structure of A. viteae chitinase genes 
2.1.1.1 Isolation and characterisation of A. viteae chitinase sequences 
from a genomic phage library 
A prerequisite to the determination of the complete genomic sequence of A. viteae 
chitinase was the isolation of clonal genomic recombinants containing the complete 
gene. To fulfil this requirement, an A. viteae genomic library in lambda dash II 
(Stratagene) was screened in plaque hybridisations using a DIG-labelled N-terminal 
cDNA sequence corresponding to nucleotides 52-1,117 of A. viteae L3 chitinase 
(Adam et al., 1996; Gene bank number U14638). The A. viteae genomic library 
(provided by Dr. Jörg Hirzmann, University of Gießen, Germany) was constructed in 
λ dash II using gDNA from a mixed population of adult worms. In the first screening at 
high stringency, 4x104 plaque forming units (PFU) were investigated giving rise to 13 
putatively positive recombinants. Following a second and tertiary screening round, 9 
of the 13 plaques remained positive and were clonal. 
2.1.1.2 Restriction analysis of genomic inserts  
Inserts of recombinant phages were subcloned into the plasmid pBluescript for 
further analysis. The genomic inserts were digested out of the lambda arms, and 
subcloned directly into the Not I site of the plasmid, pBluescript. The advantage of 
such a strategy is the ease of preparing large amounts of genomic chitinase/ 
recombinant plasmid vectors for further analysis.  
Restriction digestion of the pBluescript recombinants with Not I released genomic 
inserts ranging in size from 10-16 kb, as well as the 3 kb pBluescript plasmid (Figure 
4). For restriction analysis, recombinant DNA was digested with Not I in combination 
with EcoRI (Figure 5). Three main restriction patterns were observed. The first 
pattern was found in clones 1, 2, 11 and 13, for which digestion of full-length versions 
(clones 1 or 13) gave rise to 4.5, 3.5, 2, 1.8, and 1 kb bands.  The second pattern 
was found in clones 3, 4, 9, for which digestion of the full-length versions (clones 4 
and 9) gave rise to fragments corresponding to 5, 4.5, 1.2, 0.9, 0.8, 0.6, and 0.4 kb. 
The third pattern was found in clones 5 and 12, for which digestion of the full-length 
version (clone 12) gave rise to 5.5, 2.5, 1.7, 1.2, 0.8, 0.6, and 0.4 kb bands. A pair of 
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full-length clones from each insert group (clones 1/13, 4/9, and 5/12) was used for 
further sequencing and analysis.  
 
 
Fig. 4: Sizes of genomic inserts cloned into pBluescript  
pBluescript recombinants were digested with Not I; Clone number 1-5, 9, 11-13: individual clones 
analysed, M1: low molecular size markers, M2: high molecular size markers, M3: 14 kb linearised 
plasmid. 
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Fig. 5: Restriction analysis of Acanthocheilonema viteae genomic chitinase/ 
pBluescript recombinant plasmids.  
pBluescript recombinants were digested with Not I and EcoR I; Clone number 1-5, 9, 11-13: individual 
clones analysed, M1: low molecular size markers. 
2.1.1.3 Sequencing of A. viteae genomic chitinase and determination of 
gene structure 
Since it was technically impractical to directly sequence inserts in lambda vectors, 
overlapping PCR fragments were directionally amplified from recombinant lambda 
DNA clones using gene-specific and vector-specific primers (Figure 6) and 
sequenced. Alternatively, constructs of genomic inserts in pBluescript were also 
sequenced directly by primer walking. Three representative genomic inserts from 
clones 1, 9 and 12, identified following restriction mapping were used for sequencing. 
Independent confirmatory sequencing runs were also done with clones 4, 5, and 13 
to verify data obtained for clones 9, 12 and 1, respectively. Taking clone 12 as an 
example, gene-specific primers were used to sequence portions of the insert 
corresponding to the chitinase gene, using overlapping long PCR fragments (Figure 
6) or plasmids with the insert. These sequencing strategies were also applied for 
genomic clones 1, 4, 5, 9 and 13. 
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Fig. 6:  Long-range PCR fragments used in sequencing of genomic insert 12.  
Product A: amplified with primers T7-long range and R4 primer, product B: amplified with F3 and T3-
long range primer, product C: amplified with F4 and T3-long primer.  
Contiguous sequences were assembled from the nucleotide sequences obtained 
leading to the identification of three independent A. viteae chitinase genes (Figure 8). 
These sequences spanned about 14 kb for genomic clones 1/13, 14.5 kb for genomic 
clones 4/9, and 6 kb for genomic clones 5/12. The sequences were analysed and 
compared for the genomic organisation of the different chitinase genes using the 
published sequence for A. viteae L3 chitinase cDNA. A schematic diagram showing 
the extent to which the different insert groups were sequenced, and the genes 
predicted is shown in Figure 8. For further descriptive purposes, the chitinase 
genomic sequences have been named as gene sequence I, II, and III, respectively 
(Figure 8). Two sequences (I and III) have all features of a regularly transcribed gene: 
start methionine, followed by 12/13 exon sequences, and separated by 11/12 intron 
sequences respectively. Both sequences have a regular stop codon and a consensus 
polyadenylation signal. Generally, the splice donor and acceptor sites followed the 
common GT-AG rule (Senapathy et al., 1990), with the exception of introns e and n of 
gene II, and intron k of gene I that followed the GC-AG rule (Thanaraj and Clark, 
2001) (Appendices 1,2 and 3) and offered for the possibility of alternative splicing. 
 
To confirm the number of chitinase genes in the genome of A. viteae, Southern 
hybridisations were performed. A 700 bp dsDNA A. viteae chitinase probe was 
generated from A. viteae L3 chitinase cDNA, and hybridised under stringent 
F3T7 F4 R4 T3
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conditions to 2, 3 and 6 bands of A. viteae genomic DNA completely digested with 
Pvu II, Hind III and EcoR I, respectively (Figure 7).  
 
 
Fig. 7: Southern blot analysis of Acanthocheilonema viteae genomic DNA.  
Meriones (M) and A. viteae (A) DNA (20 µg per lane) were respectively digested with Pvu II (P), EcoR 
I (E) and Hind III (H). Alternate results are shown for digestion of Meriones DNA as control, and A. 
viteae DNA on the left side of the picture, while hybridization results for both samples are on the right.  
None of the restriction enzymes cut into the known cDNA sequence. In all three 
digested samples, the cDNA probe hybridised in different intensities to different 
bands. As completely digested DNA samples were used, the intensity of the bands 
seemed to be proportional to the number of probe molecules that bind to individual 
fragments. For the Pvu II digest that had two hybridisable bands, the band of 
approximately 15 Kb was recognised by less probe molecules than the fragment of 
9.6 Kb, suggesting that there are more binding sites for the probe on the 9.6 Kb 
fragment. This would be consistent with a cluster of similar chitinase genes on the 9.6 
restriction fragment. Further consideration of the Hind III hybridisation pattern 
suggests that there are at least three chitinase genes. Checking the corresponding 
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genomic sequences of chitinase gene I, II and III and adjacent regions up- and 
downstream, there are no Pvu II restriction sites, while there are two HindIII sites in 
each sequence that will each yield one hybridisable band within the size range 
observed. In addition, 6 hybridisable bands are expected for EcoRI, all falling within 
the range observed. 
In summary, the Southern hybridisation results support the identification of three 
different chitinase genes in the A. viteae genome, for which two genes are clustered. 
 
 
Fig. 8: Schematic diagram showing Acanthocheilonema viteae gene sequences. 
Identified genes with lettered exons are shown in boxes, while intergenic regions are shown as grey 
lines. Gene sequences were obtained by sequencing different genomic clones as described in the 
text. 
The 13 exons from gene sequence I have a 100% identity to the known cDNAs 
(Adam et al., 1996; Wu et al., 1996) as schematically represented in Figure 9. The 
signal sequence has two possible start methionines that have both been 
experimentally verified for gene I. The sequence can begin with the first start 
methionine (Wu et al., 1996) or with a second start methionine four amino acids 
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downstream (Adam et al., 1996). The Wu et al. sequence had additional 5’ UTR of 
the cDNA which are found in the upstream region of the start ATG of gene I. This 
suggests that this sequence will be expressed in the worm. Individual exons build up 
different domains which represent different structural and functional parts of the 
molecule. Exon A contains the deduced N-terminal sequence necessary for the 
secretion of the protein. The sequence for a mature protein begins in exon B with the 
conserved YVRG sequence of filarial chitinases (Fuhrman et al., 1992). The active 
glutamate is found in exon E within the conserved amino acid sequence 
FDGFDLDWEYP (Synstad et al., 2004, Watanabe et al., 1993). The glycosyl 
hydrolase domain extends from exon B to exon J. This is followed by the serine-
threonine region that has no direct relation to enzyme activity but has been 
demonstrated to facilitate enzyme secretion and to stabilize chitinase in the presence 
of proteolytic enzymes as shown in insect chitinases (Arakane et al., 2003). Finally 
exon M encodes a domain responsible for substrate binding (Fuhrman et al., 1992). 
 
 
Fig. 9:  Structure and organisation of Acanthocheilonema viteae L3 chitinase gene. 
The upper panel shows the size of the cDNA, while the lower panel shows the positions and relative 
sizes of the 13 exons and 12 introns that make up the gene. Exons are shown as boxes, connected by 
introns shown as lines.  
The exon / intron structure of gene sequence I and III are very similar. Therefore the 
exons and introns of gene I and gene III were compared as shown in Table 1. The 
amino acid sequences of the different exons show a high similarity of 77 to 97%. 
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Tab. 1:  Comparison of exon/intron sizes and identities of Acanthocheilonema 
viteae genomic chitinase sequences I and III.  
 
 
Dashes represent identities not determined due to absence of comparable sequence in one of the 
genomic sequences. NA= nucleic acid; AM = amino acid; abs. = absent. 
Overall, sequences I and III showed a relatively high homology. However, the 
greatest difference is in the region of exons K and L of gene sequence I. Exons K 
and L of gene I encode the serine-threonine rich region. This region is represented in 
gene III by one large exon named Z, which is also serine-threonine rich, but is about 
6 times larger. The sequence of exon L can be aligned to the sequence of exon Z 19 
times. Two different transcripts are therefore possible from both sequences: a 1.5 Kb 
transcript from gene I and a 2.7 Kb transcript for gene III giving a theoretical protein 
molecular weight of 55 kDa and 100 kDa, respectively. 
Gene sequence II is apparently an incomplete gene without a regular start 
methionine, but having a stop codon and a consensus sequence for polyadenylation 
(Figure 8). An additional difference in gene II is the absence of the exons encoding 
for the serine-threonine rich region.  
When gene II was compared with gene I and III, there was a higher amino acid 
identity between the exons of genes I and II (Table 2) relative to genes II and III 
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(Table 3). The identities of the intron sequences range from 10 to 100 % for 
comparable pairs.  
Tab. 2: Comparison of exon/intron sizes and identities of Acanthocheilonema 
viteae genomic chitinase sequences I and II.  
 
 
Dashes represent identities not determined due to absence of comparable sequence in one of the 
genomic sequences. NA= nucleic acid; AM = amino acid; abs. = absent. 
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Tab. 3: Comparison of exon/intron sizes and identities of Acanthocheilonema 
viteae genomic chitinase sequences II and III.  
 
 
Dashes represent identities not determined due to absence of comparable sequence in one of the 
genomic sequences. NA= nucleic acid; AM = amino acid; abs. = absent. 
In conclusion, the characterisation of nine genomic clones from an A. vieae phage 
library and Southern blot experiments revealed the existence of three different 
chitinase genes for which at least two are closely associated and might form a 
functional transcript. The major differences between the three genes are the serine-
threonine rich region (exons K and L versus Z) almost at the 3’ end of the genes. 
2.2 Comparative analysis of A. viteae genomic chitinase sequences with 
genomic data bases of nematodes 
At the moment, information is available from two nematode genomic data bases: the 
whole genomic information from the finished C. elegans project (C. elegans 
sequencing consortium, 1998) and the on-going sequencing project from the Brugia 
malayi genome (available at http://www.tigr.org). A comparison with the genomic 
sequence of chitinase gene I led to the identification of Tigr assembly 14274 that had 
the genomic sequence of B. malayi chitinase (Fuhrman et al., 1992). This sequence, 
like A. viteae chitinase, is organised into 13 exons and 12 introns, with similar 
chitinase motifs and domains being represented on the same exons. 
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Tab. 4:  Comparison of exons/ intron sizes and identities between 
Acanthocheilonema viteae L3 (Gene I) and Brugia malayi MF 1 chitinases 
 
 
 
In both genomic sequences, exon A encodes for the secretory N-terminal signal 
sequence, exons B-J for the glycosyl hydrolase domain, exons K and L for the 
serine/threonine rich linker and exon M encodes the chitin binding domain. The size 
of all exons, except exons K and L are essentially similar (Table 4). The distance 
between the ATG start codon and the stop codon is 4,566 bases as compared to 
4989 bases for A. viteae chitinase. The introns of B. malayi chitinase range in size 
from 91 bp (intron 8) to 655 bp (intron 12) as compared to 73 bp (intron 7) to 826 bp 
(intron 4) for A. viteae L3 chitinase (Table 4). The identities between introns of both 
genes range from 10% to 60%. The identities of nucleotides in corresponding exons 
are remarkably high, except for exons K and L that have a bare 30% identity. This 
kind of variation was also noticed for the analysed sequences of A. viteae chitinase 
genes. This high level of homology between the chitinase genes of these related 
filarial species is also shown by the conservation of most of the intron phases, with 
the exception of intron k (Jean et al., 2001; Guiliano et al., 2002). 
The situation in A. viteae chitinase gene sequence II in which there is no start 
methionine is comparable to a Brugia malayi genomic chitinase sequence in BAC 
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clone 1133599. In both sequences, there is no regular first exon A, and exon B has 
no regular 5’ exon/intron boundary. While A. viteae chitinase gene II has the last 
exon, a regular stop codon and polyadenylation signal, the B. malayi sequence goes 
only as far as exon J. The remaining part of the sequence has homologies to 
nematode retroviral elements like Ascaris lumbricoides proretrovirus-like element 
(Felder et al., 1994). 
In addition to these sequences, there are other large genomic assemblies with 
anotated genomic chitinase sequences in different genomic neighbourhoods. Tigr 
assembly 14932 has two chitinase genes in tandem as found on A. viteae genomic 
clones 1 and 9 (Gene II and III). The first gene (512) on this cluster has 8 exons and 
7 introns and should encode only the glycosyl hydrolase domain, while the second 
gene (514) has 10 exons and 9 introns and should encode for all domains as found 
in A. viteae chitinase gene I. 
In conclusion, B. malayi has two annotated chitinase genes, which have similar 
organisation and domain architechture like A. viteae chitinase gene I. This however 
does not exclude the existence of other chitinase genes owing to the presence of 
additional 14 genomic assemblies with exons having homologies to filarial chitinases. 
A search in the data bank of the free-living nematode Caenorhabditis elegans, 
WormBase (http://www.wormbase.org/), revealed an alignment with the highest 
probability for the C. elegans sequence C04F6.3. The gene, unlike all three 
described A. viteae chitinase, has only four exons spanning 2.22 kb of genomic DNA 
(Figure 10). The potential cDNA encodes a protein with 617 amino acids and a 
molecular weight of 66.9 kDa. Like filarial chitinases, this chitinase contains one 
glycoside hydrolase (family 18) domain, and a chitin-binding domain. Comparison of 
the gene structure revealed a comparable domain for exon A responsible for the 
secretion of the functional protein. The glycosyl hydrolase domain containing the 
catalytic site of chitinase, represented in A viteae by 9 different exons (B-J) is 
represented by exons 2 and 3 of the C. elegans chitinase gene. Thereby, exon 3 has 
an unusual size of 1313 nucleotides. Exon 3 encodes not only the glycosyl hydrolase 
domain, but contains also part of the serine-threonine linker region. Exon four of the 
C. elegans genomic chitinase sequence is clearly associated with the chitin binding 
domain as also represented by exon M of the A. viteae genomic sequences. 
Results  21 
 
Fig. 10: Comparison of genomic organisation between Acanthocheilonema viteae and 
Caenorhabditis elegans chitinase genes. 
Exons are shown as coloured boxes separated by lines representing introns. Red lines show two 
conserved intron phases with the phases indicated about the line. Intron phases are defined relative to 
the position of introns falling between codons (phase 0), within codon after first (phase 1) or second 
(phase 2) nucleotides, respectively (Jean et al., 2001a). 
Despite the high degree of similarity of certain domains, there is a bigger difference in 
exon/ intron organisation and position of introns. But, in addition to the high homology 
with filarial chitinases from B. malayi and A. viteae, is also the fact that two of the 
three possible intron phases are conserved (Figure 10), revealing the high degree of 
relationship between the worm chitinase gene sequences. 
2.3 A. viteae chitinase transcripts 
The analysis of the genomic A. viteae chitinase genes showed the existence of at 
least two potential transcripts from sequences I and III. In order to determine A. 
viteae chitinase transcripts, different approaches were used like the screening of A. 
viteae cDNA libraries as well as the specific amplification of A. viteae chitinase 
nucleic acid sequences from reverse transcribed RNA material. In addition, western 
blot experiments were performed with material from L3 stages and compared to 
already existing data. Finally, using a bioinformatic approach, the resulting data were 
compared with information from various nematode data bases. 
2.3.1 Screening of A. viteae L3 and adult female cDNA libraries for chitinase 
transcripts 
In order to identify different A. viteae chitinase transcripts and to check the stage 
specificity, two cDNA libraries made from the L3s and from gravid female worms were 
separately screened in plaque hybridisations using an A. viteae cDNA specific probe. 
The A. viteae chitinase probe was a 700 nucleic acid sequence from A. viteae 
chitinase L3 cDNA, corresponding to the exons F to J of A. viteae chitinase gene 
sequence I. The cDNA probe had a 95% identity to the nucleic acids of the 
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corresponding exons in the A. viteae gene sequence III. For both cDNA libraries, 
40,000 independent recombinants were screened. The screening procedure resulted 
in four positive plaques from the screening of the L3 cDNA library, but no positive 
plaques in the case of the female cDNA library. The resulting four clones of the L3 
cDNA revealed a similar size of 1,500 bp for the individual inserts (data not shown). 
The insert of two of these four clones from the L3 library were in vivo excised and 
sequenced. Both sequences corresponded to the already published cDNA sequence 
for the L3 stage with minor differences. There are two published L3 sequences 
(Adam et al., 1996; Wu et al., 1996). These are similar along the length of the 
molecule with the exception of the extreme 5’ end. The cDNA from Wu et al. has an 
additional alternative start methionine, followed by four more amino acids with an 
alternative start methionine. Both independently sequenced cDNA inserts from the 
cDNA library showed identical 5’ ends as published by Wu et al. (Appendices 1, 2 
and 3). In spite of the published nucleic acid sequences from Adam and Wu et al., 
there are some minor differences in the chitinase insert sequences identified from the 
L3 library (Table 5). 
Tab. 5: Nucleotide differences between published A. viteae chitinase and the 
chitinase sequence used in this study 
 
The different nucleotides are indicated and the structural changes resulting in different amino acids are 
indicated in single letter code. Codon numbering is relative to Acanthocheilonema viteae cDNA 
chitinase (Adam et al., 1996) 
Results  23 
Apart of the wobble in codon 29, all other differences are found in the variable serine-
threonine rich region. The only difference that could have come from alternative 
splicing as deduced from genomic gene I was the insertion between codons 438/439. 
All the other differences were confirmed by sequencing independent clones and 
could represent allelic differences. When all the changes are considered, it may be 
surmised that the two sequences could code for chitinases with slightly different 
physical properties, but with similar enzymatic properties since the changes do not 
occur in sites responsible for enzyme activity. 
2.3.2 Identification of A. viteae chitinase transcripts 
A total of 21 putatively positive plaques were obtained by screening a female A. 
viteae cDNA library. However, all clones did not yield any amplicons in additional 
PCR screens using vector and chitinase primers, nor did they turn out positive in 
secondary screens. 
Since the screening of a female cDNA library failed to give any chitinase transcripts, 
the next step to identify different chitinase transcripts form different parasite stages 
involved the use of RNA from uterine microfilaria and L3 stages for RT-PCR analysis. 
Accordingly, RT-PCR was done with total RNA of uterine A. viteae microfilariae and 
L3 using primer pairs designed to amplify segments of A. viteae chitinase. 
RT-PCR was done with L3 and uterine microfilarial cDNA using specific primers for 
gene sequences I and III located on exons I and M, respectively. In the first PCR 
amplification experiment, two faint bands of 1.8 and 0.6 kb were amplified with 
primers specific for gene III, and one amplification product of 0.6 kb resulted from the 
PCR with the gene I specific primers (Figure 11). A nested PCR with gene III specific 
primers did not yield specific products, while primers specific for gene I gave rise to a 
specific PCR product. Identical results were obtained with RNA from both L3 and 
uterine microfilariae. The 0.6 kb fragment amplified with the specific primers for gene 
I from the microfilarial stage was subcloned and sequenced and shown to be 100 % 
identical to the corresponding sequence for A. viteae L3 chitinase (Adam et al., 1996; 
Wu et al., 1996).  
Results  24 
 
Fig. 11:  Transcripts of A. viteae genomic sequences in L3 and microfilariae (mf) 
RT-PCR results were obtained with primers specific to genomic sequences I and III. Corresponding 
sequence-specific primers (F8 and R3) were used in RT-PCRs, while a common forward primer (F5) 
was used with specific reverse primers (R3) in nested PCRs. M, Molecular size marker. 
The fragment did not contain the terminal ends of the corresponding A. viteae L3 
transcript. As the differences between sequences I and III lie particularly in the 3’ end, 
a 3’ RACE PCR was done with RNA from uterine microfilariae, L3 and L4 to 
determine possible variations in the 3’ end. A major PCR product of 700 bp was 
obtained from all three stages as shown by the representative gel in Figure 12. The 
700 bp product from mf cDNA was subcloned in pGEM-T vector, checked by 
sequencing and shown to be 100% identical to the already published 3’ end of gene 
I. The products from L3 and L4 were confirmed by nested PCR to be transcripts of 
gene I. 
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Fig. 12: Amplification of 3’ end of cDNA chitinase from different stages using Rapid 
amplification of cDNA ends (RACE) 
Lane 1, molecular size markers; lane 2, negative control; lane 3, amplified chitinase fragment 
(indicated by arrow). 
In conclusion, a transcript for gene I could be amplified from uterine microfilariae, L3 
and L4, while transcripts for gene III could not be found in these same stages. 
However, it can not be excluded that chitinase transcripts are found in other stages. 
2.4 Identification of homologous chitinase sequences from nematode 
databases 
A blastx analysis of public data bases with cDNA sequences corresponding to exons 
of genomic gene I revealed high homologies with orthologous transcripts of filarial 
(Table 6) and C. elegans nematodes (Table 8). 
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Tab. 6: Orthologous filarial transcripts to A. viteae gene sequence I 
Sequence accession 
number 
Source of chitinase sequence 
Blastx e-value to  
gene I 
L42010 Acanthocheilonema viteae (L3) 7.3e-267 
AF250997 Wuchereria bancrofti (mf) 1.4e-197  
M73689 Brugia malayi (mf) 5.0e-194 
L42021 Onchocerca volvulus (L3) 2.1e-186 
U59689 Brugia pahangi (mf) 4.1e-166 
U59690 Brugia pahangi (mf) 8.4e-163 
NM_076187 
(C04F6.3) 
Caenorhabditis elegans 
 (embryos) 
1.9e-93 
 
With the exception of Brugia pahangi, all the other filariae have one described 
chitinase sequence. B. pahangi has two micorfilarial chitinase transcripts which differ 
in the serine threonine rich linker region (Figure 13). Comparison of the filarial amino 
acid sequences of Wuchereria bancrofti, Brugia malayi, B. pahangi, and Onchocerca 
volvulus to the A. viteae L3 chitinase sequence revealed an apparently high identity 
in the overall amino acid composition, with the exception of a region at the 3’ end that 
corresponds to the serine-threonine rich liker region between the glycosyl hydrolase 
domain and substrate binding domain (Figure 13).  
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Fig. 13:  Amino acid sequence comparison of different filarial chitinases. 
Av_chit: Acanthocheilonema viteae chitinase (Wu et al., 1996); Wban_chit: Wuchereria bancrofti 
chitinase (Raghavan et al., 1994); Bm_mf1chit: Brugia malayi chitinase (Fuhrman et al., 1992); 
Ov_chit: Onchocerca volvulus chitinase (Wu et al., 1996); Bp_chit: Brugia pahangi chitinase (Arnold et 
al., 1996). 
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A detailed analysis of the EST databases of B. malayi, W. bancrofti and O. volvulus 
revealed that B. malayi databases contain the highest number of chitinase–like ESTs. 
A clustering of these ESTs resulted in three contigs. One of the three contigs in B. 
malayi is complete and corresponds to the already published sequences for B. malayi 
microfilaria chitinase (Fuhrman et al., 1992). The other contigs are not identical to the 
published chitinase sequence (Tab 7). In conclusion, B. pahangi has two published 
microfilarial chitinase mRNAs, W. bancrofti one microfilarial chitinase, O. volvulus and 
A. viteae each has one L3 chitinase mRNA. B. malayi has a total of three chitinase 
sequences with a possible difference in stage-specific expression. 
Tab. 7: Brugia malayi ESTs 
ESTs Cluster 
or Sequence Number Stage 
Status 
of transcript 
AA022373 
AA022418 
AA246080 
AA246111 
AA598350 
H48963 
N44465 
Microfilariae 
BMC00298 
AA257830 Female 
B. malayi microfilaria 
chitinase (M 73689) 
BMC12278 AA054927 Microfilariae 
Not yet characterised: 
lysin (K) substitutes 
glutamate (E) at active 
site 
BMC18355 CD570590 
2-day 
irradiated L3 
Not yet characterised. 
Identities to other 
chitinases: 25% to A. 
viteae chitinase; 32% to 
B. malayi microfilarial 
chitinase. 
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A blastx analysis of the C. elegans database led to 21 confirmed C. elegans 
sequences with some similarity to A. viteae chitinase (Table 8).  
Tab. 8:  C. elegans homologues of A. viteae chitinase gene sequence I  
Wormpep number Secretory signal 
sequence 
Blastx e-value  to 
sequence V 
C04F6.3           yes 6.5e-102  
F07G11.9          yes 1.9e-31 
T13H5.3          yes 3.9e-25 
Y22D7AL.14 no 2.2e-23 
F15A4.8b no 3.4e-20 
F15A4.8a no 1.5e-15 
R09D1.10 no 1.5e-14 
R09D1.5 no 2.9e-13 
R09D1.8 no 3.2e-12 
R09D1.3 no 1.1e-11 
C45E5.3 no 2.7e-11 
R09D1.11 no 8.4e-11 
C25A8.4         yes 2.2e-10 
R09D1.9 no 4.9e-10 
C08H9.12 no 2.1e-09 
C08H9.14         yes 3.1e-09 
C08H9.13 no 4.3e-09 
T19H5.1 no 9.2e-09 
C08H9.11 no 1.5e-08 
M176.8 no 1.7e-07 
C08H9.7 no 3.9e-07 
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Fig. 14: Phylogenetic relationships of filarial chitinases with C. elegans chitinases 
The bootstrapped tree was rooted using chitinase from Nicotiana tabacum (Nico tab) (Gene bank: 
X78325) as outgroup. Bootstrap values for 1000 replicates are shown where they are significant 
(>700). Chitinase sequences are from the following organisms: Acanthocheilonema viteae (A vit), 
Brugia malayi (Bru ma), B. pahangi (sequence 1= Bru; sequence 2 = Bru pah), Onchocerca volvulus 
(O vol) and Wuchereria bancrofti (W ban). All other sequences are from Caenorhabditis elegans. 
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C04F6.3 represents the C. elegans chitinase with highest homology and phylogenetic relationship to 
the filarial chitinases. 
 
Fig. 15:  Amino acid sequence comparison of Acanthocheilonema viteae chitinase with 
Caenorhabditis elegans sequence C04F6.3. 
Regions corresponding to different domains are indicated with a line closely apposed to the sequence: 
Green, signal sequence; Blue, glycosyl hydrolase domain (the same for both sequences); Yellow, 
serine-threonine rich linker; Red, chitin binding domain. 
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Following phylogenetic analysis of confirmed C. elegans chitinase with other filarial 
chitinase sequences (Figure 14), C. elegans sequence C04F6.3 clustered with the 
filarial chitinases from A. viteae, B. malayi, B. pahangi, O. volvulus and W. bancrofti. 
An alignment of C04F6.3 with A. viteae chitinase is shown in Figure 15. There is a 
great difference in similarity between the two derived protein sequences. Though the 
overall identity between both sequences is barely 34 %, a general analysis reveals 
the presence of the four important motifs described for family 18 chitinases: there is a 
secretory signal sequence, a glycosyl hydrolase domain, a serine-threonine rich 
linker region, and a substrate binding domain. The important consensus sequence of 
the active site is fully conserved.  
In conclusion, C. elegans has several family 18 chitinase genes, one of which is 
closely related to the filarial chitinases. 
2.5 Cloning, expression and purification of recombinant A. viteae 
chitinase 
2.5.1 Cloning, periplasmatic/ cytoplasmatic expression and purification of N-
terminal portion of A. viteae chitinase in the expression vector pET 22 b 
(+) in E. coli  
The DNA sequence of the glycosyl hydrolase domain, corresponding to nucleotides 
52-1,117 of A. viteae L3 chitinase was subcloned into the pET 22 b(+) vector, leading 
to the expression of a protein with an N-terminal vector-specific bacterial signal 
sequence and a C-terminal 6- His tag for purification. The bacterial signal sequence 
allows for potential periplasmatic localisation of the expressed protein and 
subsequent release of the bacterial signal sequence by bacterial signal peptidases. 
This construct was transformed into BL 21 (DE3) E. coli cells, and expressed as a 
protein of 43 kDa representing about 40 % (about 7 mg) of the total bacterial 
biomass, following induction with IPTG as shown in Figure 16. The protein could be 
exported into the periplasmatic space, released through osmotic shock and purified 
by affinity chromatography from the osmotic shock fluid (Figure 16). As shown on 
SDS-PAGE in Figure 16, there is a main band representing N-terminal chitinase 
without any signal sequence, while there is a minor band that runs slightly higher and 
should represent the soluble cytoplasmic fraction with the intact bacterial signal 
sequence. The total soluble protein purified represented about 15 % of the total 
protein expressed corresponding to 1.1 mg protein from 500 ml bacterial culture.                                        
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Fig. 16: Expression and purification of A. viteae chitinase from the periplasmatic 
space 
Lane 1, low molecular weight marker; lane 2, lysate of non-induced bacteria (N); lane 3, lysate of 
induced bacteria (I); lane 4, eluted fraction from a Ni-NTA column of A. viteae chitinase (arrow) 
The insoluble cytoplasmic fraction was solubilised in 8 M urea and also purified by 
affinity chromatography (Figure 17). The purified protein in urea was then dialysed 
successively against decreasing concentrations of urea in phosphate buffer. A greater 
part of the protein (4mg) precipitated during dialysis giving rise to just over 1mg 
soluble protein per 500 ml bacteria culture. 
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Fig. 17: Expression and purification of A. viteae chitinase under denaturing conditions 
Lane 1, lysate of non-induced bacteria (N); lane 2, lysate of induced bacteria (I); lanes 3-5, fractions of 
A. viteae chitinase eluted from Ni-NTA column. 
2.5.2 Activity of N-terminal chitinases 
The activity of the N-terminal fragment of chitinase, purified from the cytoplasmic as 
well as from the periplasmatic space, was assessed using the substrate 4-
methylumbelliferyl ß-N’,N’’,N’’’ chitotrioside that releases the fluorescent product 4-
methylumbelliferone upon cleavage by a glycosyl hydrolase. Recombinant N-terminal 
A. viteae chitinase, purified under denaturing conditions and dialysed against 
phosphate buffer, was shown to have chitinase activity that had about 50 times less 
specific activity (defined as relative fluorescent units per hour per ng protein) as 
compared to the positive control, which was Baculovirus expressed O. volvulus 
chitinase (New England Biolabs) (Figure 18, Table 8). The negative control protein, A. 
viteae cystatin (Av17) did not hydrolyse the substrate. 
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Fig. 18:  Activity assay of purified cytoplasmic N-terminal chitinase 
Activity assays were done with A. viteae chitinase (pink line), O. volvulus chitinase as positive control 
(blue), and Av 17 (filarial cystatin) as negative control. The amounts of protein assayed were 1.043 ng 
O. volvulus chitinase, 38.5 ng A. viteae chitinase and 38.5 ng Av 17. 
Tab. 9:  Specific activity of purified A. viteae and O. volvulus chitinases 
      
 
 
The specific activities of A. viteae and O. volvulus chitinases are shown. *The specific activity is 
reported as relative fluorescence units per hour per ng protein used. 
The activity of A. viteae N-terminal chitinase purified from the periplasmatic space 
was originally determined using Serratia marcescens chitinase (Sigma) as standard. 
The relative fluorescence units were estimated to have about 30 % of the activity of 
baculoviral expressed O. volvulus chitinase (New England Biolabs) (data not shown). 
2.6 Immunisation studies with A. viteae chitinase in Meriones 
unguiculatus 
For the evaluation of protective potentials of different vaccines, Meriones were 
vaccinated and subsequently challenged with 70 L3s of A. viteae. Two preparations 
were used in this study, namely recombinantly expressed glycosyl hydrolase domain 
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(N-terminal fragment) of A. viteae chitinase, and synthetic peptides designed from the 
active site of A. viteae chitinase. 
2.6.1 Immunisation studies with A. viteae N-terminal chitinase fragment 
Recombinant N-terminal chitinase of A. viteae was used in vaccination experiments 
with STP and Alum as adjuvants. Immunisation experiments were done following the 
scheme on Figure 19. Ten-week-old Meriones were given a primary immunization 
subcutaneously at the flanks with 25 µg protein, followed by two boosters on the 2nd 
and 4th weeks before challenge. Meriones were bled for sera on weeks –6, 0, 4, 8 
and 12, and the microfilaria load was checked on the 8th and 12 weeks following 
challenge. Meriones were sectioned for retrieval of adult worms on the 12th week 
after challenge (Figure 19).  
 
 
Fig. 19: Immunisation scheme of Meriones unguiculatus with experimental vaccines 
 
Recombinant N-terminal A. viteae chitinase purified under denaturing conditions was 
used in the immunization of 10-week-old Meriones with STP and Alum as adjuvants. 
During the course of the experiment, one animal died from the chitinase/ Alum group, 
two from the chitinase/ STP group, three from the STP group and three from the PBS 
group (Table 10). Vaccination of Meriones with the glycosyl hydrolase domain of 
chitinase and STP as adjuvants led to a 29%  significant overall reduction in worm 
burden (p< 0.05), while vaccination with Alum as adjuvant did not lead to any overall 
reduction in worm burden (Figure 20, Table 10). 
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Tab. 10: Summary of biometric data from immunization studies with  N-terminal 
Acanthocheilonema viteae chitinase 
Antigen/ control Chitinase/ 
Alum 
Chitinase/ 
STP 
Alum STP PBS  
Worms 
recovered 
20.16±6.43 17.4±3.43 20.57±3.59 24.5±4.65 24.85±4.84 
Female worms 
(Length) 
13.83±4.4 
(4.7±0.4) 
11 ±2.5 
(4.57±0.3) 
13.57±3.4 
(4.55±0.3) 
14.25±2.7 
(4.7±0.4) 
13.42±3.4 
(4.79±0.4) 
Male worms 
(Length) 
9.2±5.5 
(2.08±0.1) 
6.4±4.3 
(2.35±0.1) 
8.5±4.1 
(2.2±0.1) 
10.25±2.7 
(2.19±0.1) 
11.42±2.7 
(2.2±0.2) 
Mf density / ml 
blood 
285±117.8 216.2±46.2 265±100.2 220±116 432.4±350 
Surviving 
animals 
6/7 5/7 7/7 4/7 7/10 
 
 
 
Fig. 20:  Immunisation of Meriones unguiculatus with N-terminal Acanthocheilonema 
viteae chitinase 
The number of worms recovered following immunization with N-terminal chitinase (rA. viteae chitinase) 
and STP and Alum as adjuvants are shown. Controls: Alum and STP.  
When the microfilaria load was compared, there was no statistically significant 
difference in the microfilarial burden between experimental and control groups on the 
10th week following challenge infection (Table 10). There was equally no statistically 
significant difference in the lengths of the worms obtained from experimental and 
control groups (Table 10).  
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2.6.2 Immunisation studies with synthetic peptides from the active site of A. 
viteae chitinase 
To investigate whether antibodies towards the active site of A. viteae chitinase could 
inhibit chitinase and thus lead to protection against challenge infection, synthetic 
peptides were used in immunization studies. The synthetic peptides were designed 
from the active site of A. viteae chitinase. For the identification of relevant amino 
acids, the process of homology modeling was used. Coccidiodes immitis chitinase, a 
family 18 chitinase whose structure is known, was used as a template to predict the 
structure of O. volvulus chitinase. The corresponding amino acids were then obtained 
from A. viteae chitinase following alignment with O. volvulus chitinase. Homology 
modeling and synthesis of peptides were done respectively by Professor Höhne and 
Dr. Volkmer-Engert of the Charité Medical Faculty, Humboldt University of Berlin. 
Three candidate peptides were identified (see materials) and synthesized, and two 
turned out to be soluble. To investigate whether the two peptides could generate a 
specific immune response, they were coupled to a KLH carrier protein and 100 µg of 
coupled peptide/ KLH was used to immunize BALB/c mice with Alum as adjuvant. 
The sera of immunized mice could recognize full-length native A. viteae chitinase in 
western blots with A. viteae L3 total antigen (Figure 21).  
 
Fig. 21:  Recognition of native Acanthocheilonema viteae L3 chitinase by sera of mice 
immunized with peptides.  
Western blot reactions are shown for zero bleeds (0) and the reaction of antisera of peptides 1 and 2 
to native chitinase. Positive control: Antisera to N-terminal chitinase protein. 
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The sera from animals immunized with P1 gave stronger reactions than sera from 
mice immunized with P2.The two synthetic peptides, P1 and P2, were then coupled 
with KLH and used for immunization. The coupled peptides (100 ug) were 
administered with alum as adjuvant at the flanks of the animals. Alum was used as 
adjuvant to shift the immune response towards the Th2 direction since the initial 
premise was to produce neutralizing antibodies to the active site of chitinase. 
Boosting, bleeding, challenge and section were done as in section 2.6.1.  
A summary of the biometric data obtained from both experiments is shown in Table 
11.  
Tab. 11: Summary of biometric data from immunization studies with synthetic 
peptides from Acanthocheilonema viteae chitinase 
Experiment A 
Antigen/ control Peptide 1/ Alum Peptide 2/ Alum Control alum Control PBS 
Worms recovered 17.2±7.1 24.3±7.6 24.5±5.6 29.5±10.1 
Female worms 
(Length) 
10.7±4.8 
(4.99±0.15) 
13.9±3.5 
(5.16±0.46) 
13.3±3.8 
(5.08±0.21) 
16.4±5.4 
(5.25±0.65) 
Male worms 
(Length) 
6.5±2.2 
(2.29±0.18) 
10.4±4 
(2.36±0.17) 
11.2±2.8 
(2.22±0.2) 
13±5.2 
(2.44±0.22) 
Mf density / ml blood 274±146 574±215 439±54 456±152 
Surviving animals 4/7 5/7 6/6 9/11 
 
Experiment B 
Antigen/ control Peptide 1/ Alum Peptide 2/ Alum Control PBS 
Worms recovered 25±3.2 24.7±5.3 33.1±10.2 
Female worms 
(Length) 
15±4.2 
(5.02±0.7) 
11.8±4.6 
(4.58±0.7) 
19.1±4.8 
(5.15±0.9) 
Male worms 
(Length) 
10.3±2.1 
(2.32±0.3) 
10±2.1 
(2.31±0.3) 
14.7±7.2 
(2.38±0.4) 
Mf density / ml blood 443.2±171.8 208.1±58.5 833±384.2 
Surviving animals 6/6 6/6 9/11 
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Fig. 22: Vaccination of Meriones with KLH-coupled chitinase peptides 1 and 2 
The diagram shows the worm burdens following vaccination with 2 different chitinase peptides in two 
independent experiments, A and B.  
There was no significant difference in the lengths of the worms recovered from both 
experimental and control groups, indicating that immunization with the peptides may 
not have influenced the growth of the worms.  
In two independent immunization experiments, data from animals vaccinated with 
peptide 1 suggested a trend towards decrease (33% and 23.4 %) in worm burden as 
compared to the control groups (Figure 22; Table 11). The first experiment was 
stopped at week 10 owing to death of animals in different groups (Table 11). 
Vaccination of Meriones with peptide 2 did not lead to an overall decrease in worm 
burdens in the first experiment, but showed a tendency towards decrease (25.5 %) in 
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worm burden in the second experiment (Figure 22). In the first experiment, the 
microfilaria load was significantly reduced (p<0.05) in the group of Meriones 
immunized with chitinase peptide 1 (Figure 23), while the chitinase peptide 2 group 
showed no tendency towards reduction. 
In the second experiment, the microfilaria load was compared between experimental 
and control groups on the 12th week following challenge, and it could be shown that 
vaccination with chitinase peptide 1 and peptide 2 led to 45% and 75% significant 
reductions in microfilaria load (p< 0.05) , respectively (Figure 23). 
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Fig. 23: Microfilaria burden from Meriones vaccinated with KLH-coupled chitinase 
peptides  
The microfilaria burden following vaccination with chitinase peptides (chit pep) 1 and 2, as well as 
Alum and PBS controls are shown.  
A 
B 
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3 Discussion 
3.1 Analysis of A. viteae chitinase genes and transcripts 
One of the major goals of our study was the characterisation of A. viteae chitinase 
genes. This involves the description of the genomic structures as well as the 
characterisation of different transcripts of the individual stages of the life cycle of A. 
viteae.  
According to our studies, the genome of A. viteae contains three different chitinase 
genes.  
Southern blot analysis showed, particularly for the Pvu II digest, that there are at 
least two different chitinase genes. However, the different band intensities of 
especially the Pvu II digest could be explained by the fact that the probe bound at 
least twice more to close gene copies on a single DNA fragment. This indicates that 
there is a cluster with of a minimum of two chitinase genes. A similar suggestion was 
made by Arnold and colleagues (1996), who investigated gDNA from B. malayi for 
chitinase genes. The variation in the intensity of individual bands was also explained 
by the existence of a gene cluster. Further analysis of nine genomic sequences from 
a gene library of A. viteae worms confirmed the existence of three independent 
chitinase gene sequences. The sequences of two genomic clones (1 and 9) had a 
cluster of two genes as predicted from Southern hybridisation results, and an 
identical overlapping region with some minor differences. The corresponding 
genomic region of two inserts comprises a length of 6,845 bp, of which 93% was 
identical between two pairs of genes. The main differences arose from the beginning 
of insert 1, the end of insert 9, a repeating sequence of 25 nucleotides and a non-
matching region in the intergenic region of both sequences. An additional argument 
for the identity of both sequences is the fact that the introns of both pairs of chitinase 
genes were 100% identical. This strongly indicates that the two pair of sequences are 
identical because intron sequences should show a higher mutation rate (Neafsey et 
al., 2005) since they are not under evolutionary pressure as exon sequences coding 
for particular amino acids responsible for the function of a protein. This hypothesis 
was confirmed by sequencing two independent clones (13 and 4) with similar 
restriction maps like clones 1 and 9. Analysis showed that the incomplete gene 
sequences at the beginning of clone 1 and at the end of clone 9 were truncated 
versions of gene sequences II and III, respectively. The discrepancies initially 
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observed could have been due to sequencing errors or to artefacts inherent in the 
construction of the genomic libraries. 
In consequence, there were three independent genomic chitinase sequences that 
were very similar in the structure, and showed the highest degree of variation in 
exons for the serine threonine rich domain in the 3’ part of the genes. A comparison 
with the structure of the B. malayi MF 1 chitinase gene showed that the whole 
structure of the genes is identical to the A. viteae genes, with the only difference 
being in the exons coding for the serine threonine rich domain. There are three other 
annotated chitinase genes in B. malayi having a broad range of organisations with 
some domains and exons fully, partially represented or absent (http://www.tigr.org). 
The absence of some exons in these genomic sequences could be seen as a 
footprint of unequal recombination occurring between exons of homologous and 
nonallelic chitinase genes (Maeda and Smithies, 1986). Interestingly, two of these 
chitinase genes are found in tandem on the same genomic assembly. Taken into 
account that a similar situation was demonstrated for A. viteae, it may be surmised 
that these genes exist in a cluster in these filarial parasites and are consequently a 
hot spot for recombination. 
A. viteae chitinase gene sequence II, in contrast to sequences I and III, had no first 
exon with a start ATG and probably no functional transcript. A comparable sequence 
is found in the genome of B. malayi. Both sequences lack a first exon, and have an 
irregular second exon, a situation which may have arose by unequal crossing over 
resulting to the loss of the 5’ exon with the start ATG (Maeda and Smithies, 1986). 
While A. viteae gene II has a regular stop codon and polyadenylation site, and may 
thus be considered as part of a true gene, the B. malayi sequence is definitely a 
pseudogene due to the presence of proretrovirus-like elements after the 10th exon 
(Felder et al., 1994), and to an alteration of the reading frame.  
 
The gene structure for the chitinase gene of the free living nematode C. elegans has 
a different distribution of exons coding for the enzymatic domain and for the serine- 
threonine rich linker structure. An unusually long exon codes for the glycosyl 
hydrolase domain responsible for the catalytic activity of the deduced protein, and for 
most of the serine threonine rich linker region. The exons coding for the secretory 
signal sequence and the chitin binding domain correspond to those in the filariae. 
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The C. elegans chitinase is an orthologue of the filarial chitinases, despite the lack of 
similar introns and conservation of all intron positions and phases. This is congruent 
with the clustering of all of these sequences in a phylogenetic tree, and to the fact 
that no other C. elegans chitinase has a better match to filarial chitinases than this C. 
elegans chitinase. A similar observation was made by comparing an 83 kb synthenic 
region between B. malayi and C. elegans and demonstrating that corresponding 
orthologous genes clearly had differences in gene structure (Guiliano et al., 2002). 
Apart of this chitinase, there are some other 30 expressed chitinase genes in C. 
elegans, whose implication and function have not been addressed 
(www.wormbase.org; Popovici et al., 1999).  
It is not known why C. elegans has many more chitinase genes than the filarial 
nematodes. The C. elegans chitinase gene family is made up of many orthologues 
and homologues that may have arisen by duplication and diversion of a common 
ancestor gene (Popovici et al., 1999). Though the function of all the members of this 
gene family is not yet known, diversion may have led to new copies with different 
functions as well as tissue or substrate specificities. Some of the genes are very 
identical with up to 10 nonallelic copies clustered on one chromosome, while others 
have very low identities and are widely dispersed on different chromosomes. A 
general conclusion drawn from the C. elegans chitinases would be that there may be 
more members of a gene family than one could suspect on the basis of protein 
analysis and by the use of probes to fish out identical genes of the same family. This 
is supported by the fact that many of the chitinase genes share common motifs, but 
have very low sequence identities. In line with this hypothesis, there may be several 
other chitinase genes in the filarial nematodes which have not been characterised 
based on the low identities they share with known family members. Support for this 
hypothesis comes from the B. malayi irradiated L3 chitinase EST that has a bare 32 
% identity to the published sequence for B. malayi chitinase. Another observation 
showing that such a phenomenon is present in the filarial genome is the description 
of two chitin synthases in Brugia with a bare 27% identity (Harris et al., 2000; Foster 
et al., 2005). The existence of orthologous genes with the same function in a parasite 
makes it difficult to effectively use these genes as vaccine or drug targets. Thus, the 
further characterisation of filarial chitinases as drug or vaccine targets will entail the 
identification and/or exclusion of further functional chitinase genes in the nematode of 
interest. 
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In keeping with the identification of three chitinase genes in A. viteae it was 
hypothesised that there could be several stage-specific A. viteae chitinase genes 
which may have different substrate specificities or functions. There are two published 
A. viteae chitinase cDNA sequences (Adam et al., and Wu et al., 1996) that differ 
only in the outmost 5’ ends. The Wu et al., sequence begins with a start methionine 
and three additional amino acids which are absent in the Adam et al., sequence. 
Within the frame work of this study, data from cDNA and genomic sequences could 
confirm that the Wu et al., sequence is the variant that is expressed in vivo. The 
exons of A. viteae genomic gene I are 100% identical to the sequence of Wu and 
colleagues, particularly with regards to the 5’ end. Transcripts could actually be found 
for this sequence in uterine microfilaria, blood microfilariae, L3 and L4, while no 
transcripts could be found for gene sequence III. It would however not be excluded 
that other A. viteae chitinase-like transcripts could be present in A. viteae, since 
western blot data show the existence of four molecules reacting with antibodies to A. 
viteae chitinase. It was shown that sera of Meriones protected by vaccination with 
irradiated L3 were mainly directed against L3 molecules of 205 kDa, 68 kDa and 17 
KDa (Lucius et al., 1991). The 205 and 68 KDa molecules were characterised as 
chitinases (Adam et al., 1996). In addition, monoclonal antibodies produced from 
sera of animals immunised with irradiated attenuated L3 and Excretory secretory 
products (ESP) could recognise an array of molecules in different filarial stages in 
immunoblots (Adam et al., 1996). Amongst others, a 68 kDa chitinase could be 
shown for L3 and L4, while 220 kDa, 205 kDa and 140 kDa molecules were found in 
female worms, L3 and microfilariae, respectively. The authors proposed that the 205 
kDa L3 molecule could be as a result of oligomers formed from the 68 kDa 
monomers, or post-synthetic modification of the monomer. The antigens from female 
worms were shown to be from uterine microfilariae (Adam et al., 1996). The 
implication of such a finding could be that there are possibly different stage-specific 
chitinases in microfilariae and L3 of A. viteae. While we have demonstrated that the 
same chitinase molecule (68 kDa) is expressed in mf, L3 and L4, it remains to be 
shown that there are other chitinase messages in different parasite stages. 
Filarial chitinases had been exclusively attributed to the L3 and mf stages of A. viteae 
and O. volvulus (Wu et al., 1996; Adam et al., 1996) or to the microfilarial stages of 
Brugia (Fuhrman et al., 1992; Arnold et al., 1996). However, Brugia EST data point to 
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the existence of a novel chitinase transcript in B. malayi L3, a stage from which no 
chitinase gene had previously been characterised. In this study, we showed chitinase 
transcripts in uterine microfilaria and L3 and L4, but not in the cDNA library from adult 
female worms, even though the uterine microfilariae were derived from gravid female 
worms. A similar difficulty was found in the isolation of B. malayi chitinase from 
microfilaria (Southworth et al., 1996) and O. volvulus chitinase (Perler, personal 
communication) from a female cDNA library. In both cases, the reasons advanced 
were the low representation of chitinase transcripts in the total transcript population of 
the filarial stages looked into, or suboptimal isolation of targeted transcripts from 
these filarial stages (Southworth et al., 1996; Perler, personal communication).  
 
A comparison of the deduced amino acid sequences from the three A. viteae 
chitinase gene sequences revealed a very high rate of identity except for the serine 
threonine rich linker region. The variation in the serine threonine rich linker region of 
A. viteae chitinase is also found when different filarial chitinase sequences are 
compared. It is not known whether the size and composition of the serine threonine 
rich linker are of particular relevance to the function of the protein. However, this 
region has several consensus sequences for glycosylation and when glycosylated 
will influence protein solubility, secretion and the resistance of the protein against 
proteases as has been demonstrated for insect chitinases (Arakane et al., 2003). 
Such properties could be of particular relevance to the host-specificity of parasites 
and their chitinase molecules. 
 
The function of chitinases in filarial worms is not yet known. However, in protozoan 
parasites like Plasmodium and Leishmania, chitinase has been shown to be 
important for transmission by their role in lysis of the arthropod peritrophic matrix 
(Langer and Vinetz, 2001; Romalho-Ortigao and Traub-Cseko, 2003). While 
Simulium vectors of O. volvulus have been reported to have peritrophic membranes 
(Ramos et al., 1994; Demanou et al., 2003; Soumbey-Alley et al., 2004), such 
membranes have not been demonstrated in tick vectors of A. viteae (Sonenshine, 
1991). It is therefore not known whether similar mechanisms operate in these 
vectors. However, L3 chitinases of O. volvulus and A. viteae could have a role in the 
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egress of these parasites from their arthropod vectors since their expression 
coincides with the transmission of the parasites (Wu et al., 1996). 
If chitin is the unique substrate for filarial chitinases, it may be speculated that 
chitinases play a role in parasite transmission based on two observations. Firstly, 
Brugia microfilariae express chitinase; secondly, it has been shown that Brugia 
microfilariae not expressing chitinase could not penetrate the arthropod vector 
(Fuhrman et al., 1987). It is hypothesised that lectins or agglutinins in the arthropod 
midgut binds to the microfilariae and reduces their infectivity. Chitinase promotes 
infectivity by digesting its substrate and releasing N-acetylglucosamine (GlcNAc) that 
saturates the lectins and reduces their interaction with microfilariae. Such a 
hypothesis has been proven in other parasite systems by supplementing the infection 
blood meal with N-acetylglucosamine, the monomers of chitin, which in turn 
increases infectivity (Welburn et al., 1993). Such a hypothesis can be tested in the 
filariae by carrying out similar experiments. 
Parallel to the role of insect chitinases in ecdysis (Kramer and Muthukrishnan, 1997), 
filarial chitinases are speculated to be involved in moulting and hatching, since filarial 
eggs and adult sheath have been shown to contain chitin (Harris et al., 2000; Brydon 
et al., 1987). Such a role in ecdysis was suspected for A. viteae chitinase by the 
expression of chitinase on the surface of microfilaria, just before they hatch from their 
modified eggshell, and the absence of chitinase in blood-borne microfilaria (Adam et 
al., 1996). 
3.2 Expression, purification and activity of N-terminal chitinase 
There are three possibilities to control filarial infections: vector control, 
chemotherapeutic control, and immune control through vaccines. Chitinase is an 
attractive target for vaccine and drug control, since it is an enzyme that is expressed 
in two key stages (microfilariae and L3s) in the life cycle of filariae. In addition, knock 
out experiments with the C. elegans chitinase orthologue show that this gene is 
important for the development of larvae that are the equivalent of microfilariae in the 
filarial nematodes (www.wormbase.org). Moreover, knowledge on the structure of 
filarial chitinases will help towards the development of selective inhibitors against 
these molecules. Chitinase inhibitors might at the same time also target other chitin-
containing pathogens like fungi and arthropods. For these reasons, it was necessary 
to produce large amounts of soluble and active A. viteae chitinase. 
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A bacterial expression system was chosen for the expression of A. viteae chitinase. 
The chitinase gene was cloned into the pET 22 b (+) vector (Novagen) and could be 
expressed in a suitable E. coli host. Expression and purification of large amounts of 
soluble full-length molecule was not possible, and so the N-terminal portion 
corresponding to the glycosyl hydrolase domain of the molecule was expressed. 
Failure to obtain a full-length molecule could have been due to difficulties in disulfide 
bond in the substrate-binding domain of the molecule that contains 6 cysteins. 
Amongst other things, the expression of soluble active chitinases from filarial 
paraistes (Southworth et al., 1996; Drabner et al., 2001) and other parasites like 
Leishmania (Razek-Desoukey et al., 2001) has always been difficult due to the 6 
cysteins in the chitin binding domain, which disturbs proper folding. To overcome 
these problems of expressing soluble proteins in heterologous genes in E. coli, 
different strategies are used like reduction in induction temperature (Schein and 
Noteborn, 1989; Razek-Desoukey, 2001), using different bacteria expression hosts 
(Vinetz et al., 1999), fusion with a solubility-enhancer tag (Davis et al., 1998), export 
of the protein into the periplasmatic space (Southworth et al., 1996), and expression 
of truncated forms or independent domains of the molecule (Southworth et al., 1996). 
The glycosyl hydrolase domain of chitinases folds independently of the substrate-
binding domain (Synstad et al., 2004; Fusetti et al., 2003), and both domains are 
independently stable and active (Henrissat and Bairoch, 1993, 1996; Arakane et al., 
2003) (http://afmb.cnrs-mrsfr/CAZY)). In this perspective, studies on chitinase activity 
and inhibitor binding could be made with the N-terminal glycosyl hydrolase domain of 
the molecule. For this reason, the N-terminal glycosyl hydrolase domain of A. viteae 
chitinase was cloned into the vector pET 22 b (+) and expressed in BL 21 (DE3) E. 
coli cells. Most of the protein was insoluble and could be purified only under 
denaturing conditions. There was a marginal increase in protein solubility when 
expression was done at lower temperatures. Export into the periplasmatic space 
produced little amounts of soluble material, which was 16 times more active 
compared to the cytoplasmic protein. A comparable 12-fold increase in the activity of 
a B. malayi MBP fusion chitinase was obtained upon export of the protein into the 
periplasmatic space (Southworth et al., 1996; Venegas et al., 1996). The increased 
specific activity of chitinase exported into the periplasma could be attributed to the 
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better folding conditions in the periplasm as opposed to the cytoplasm (Rietsch et al., 
1996; Raina and Missiakas, 1997; Sone et al., 1997).  
Since most of the chitinase was expressed as insoluble material in the cytoplasm, 
bacteria hosts that enhance protein solubility in the cytoplasm were used for 
expression. Bacteria strains like Origami B (DE3) carry the trxB and gor mutations 
that enhance the formation of disulfide bonds in the cytoplasm (Derman et al., 1993; 
Aslund et al., 1999) and increase protein solubility. The use of this strain led to a 4-
fold increase in chitinase solubility and a 13-fold increase in activity as compared to 
chitinase purified under denaturing conditions.  
In order to obtain much more active A. viteae chitinase, current efforts are directed 
towards a eukaryotic expression system like insect cells. The reasons for this are 
two-fold. Firstly, glycosylation may lead to an increase in filarial chitinase activity 
(Fuhrman et al., 1992; 1995). Secondly, a commercially available eukaryotically 
expressed O. volvulus chitinase was shown to be 4-fold active compared to the A. 
viteae chitinase in this study. The eukaryotic expression system offers better folding 
conditions and the possibility of post-synthetic modifications, which are absent in the 
prokaryotic expression system (Vialard et al., 1995).  
3.3 Immunological control 
Several independent observations and experiments hint to the development of 
protective immunity against filariae. In natural endemic populations, there are 
putatively immune (PIs) individuals (Elson et al., 1994; Turaga et al., 2000) with no 
current or past evidence of filarial infections. In natural and surrogate model systems 
for filariasis, immunisation with irradiated infective stage larvae led to near-sterile 
immunity (Lucius et al., 1991; Prince et al., 1992; Lange et al., 1993; Taylor et al., 
1994; Johnson et al., 1998; Trees et al., 2000). However, the expression of identified 
filarial vaccine candidates as E. coli expressed recombinant proteins or as DNA 
vaccines in various models led to varying rates of protection  that did not match up to 
the almost complete protection rates achieved by the use of irradiated third-stage 
larvae (Lustigman et al., 2002; Cook et al., 2001; Abraham et al., 2002). This failure 
to mimic vaccination with attenuated parasites can be due amongst others to the 
absence of non-protein moieties, like in phosphorylcholine and carbohydrates in the 
recombinant vaccines (Nutman, 2002). In addition, native-protective antigens may 
have a different tertiary structure and thus a greater capacity to induce protective 
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immunity as opposed to recombinant proteins. This is consistent with observations in 
the cestodes for which the initial use of native vaccine antigens has led to the 
development of successful vaccines (Lightowlers et al., 2003). The paucity of starting 
material however limits such an approach in the filarial nematodes. Thus the use of 
heterologous nematode protein expression systems may lead to the faithful 
expression of native proteins. 
 
An understanding of the protective mechanisms in PIs and the irradiated L3 
vaccination models will help in targeted development of potential vaccines. The 
protective mechanisms in PIs is not clearly associated with any of the arms of 
immunity: antibody responses (Stewart et al., 1995; Boyer et al., 1991) as well as Th1 
and Th2 responses (Turaga et al., 2000) have been described. On the other hand, 
protective immunity associated with vaccination using irradiated larvae was clearly 
dependent on Th2 responses and involved antibodies and eosinophils (Le Goff et al., 
2000; Lange et al., 1994; Bleiss et al., 2002). A role for antibodies in natural systems 
is provided by the elevated levels of IgG1/ IgG3 in protected subjects (Stewart et al., 
1995) and the demonstration that sera from both infected and protected subjects 
mediate adherence and killing of microfilariae (Brattig et al., 1991) and infective 
larvae (Johnson et al., 1994). 
  
Filarial chitinases could be considered as targets for immune attack based on two 
observations: the sera of PIs differentially recognise filarial chitinase molecules as 
opposed to clinically infected individuals (Rhagavan et al., 1994); and the sera of 
rodents immunised with irradiated A. viteae L3s dominantly recognised L3 chitinase 
in blots (Adam et al., 1996). Moreover, a monoclonal antibody, that mediated 
microfilarial clearance upon transfer, recognised B. malayi microfilaria chitinases in 
western blot (Canlas et al., 1984a; Canlas et al., 1984b). 
In addition to these observations, confirmatory vaccination studies were done with 
filarial chitinases from O. volvulus leading to a 53% significant reduction in worm 
burden (Harrison et al., 1999). 
It may therefore be surmised that eliciting the right antibody response against 
chitinase would contribute to immune protection. 
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The catalytic and substrate binding domains of chitinase have been shown to have 
different immunological properties (Venegas et al., 1996; Wu et al., 2001). We 
hypothesized that an increased antibody response to the glycosyl hydrolase domain 
and/or the active site of A. viteae chitinase will lead to the selective inhibition of 
chitinase activity and function, and an inhibition in the development of stages 
associated with this enzyme. The use of antibodies to epitopes or peptides from 
active sites of enzymes has been shown to be a successful tool for vaccination in 
cases where the enzyme appears at critical points in the life cycle of a parasite. 
Passive transfer of monoclonal antibodies binding to the active site of glutathione S-
transferase of the nematode Schistosoma bovis impaired egg development, and this 
property was in turn correlatated with the enzyme inhibition (Da Costa et al., 1999). 
Using a similar strategy, it has been shown that vaccination of rabbits with synthetic 
peptides from the active site of Helicobacter pylori urease produced neutralising 
antibodies, and was a useful vaccination tool (Hirota et al., 2001). Synthetic peptides 
can be obtained from active sites of enzymes by homology modelling using other well 
characterised enzymes (Fujii et al., 2004).  
The N-terminal catalytic domain of chitinase, as well as synthetic peptides designed 
from the active site of A. viteae chitinase 3-D model, was used in immunisation 
studies. Immunisation with the whole catalytic domain with STP as adjuvant led to a 
significant reduction in worm burden in a unique experiment. When alum was used 
as adjuvant, there was no tendency towards reduction in worm burden. 
Despite the fact that STP was shown to be the better adjuvant for immunisation, alum 
was used for immunisation studies involving synthetic peptides, since our premise 
was to induce neutralising antibodies to the active site of chitinase. Alum is an 
adjuvant that directs the immune resonse to the Th2 direction /humoral arm.  
Immunisation with the synthetic peptides showed a tendency towards an overall 
decrease in worm burden in two independent experiments. In these same 
experiments, the group vaccinated with peptide 1 had a consistent significant 
reduction in microfilaria load, while the group vaccinated with peptide 2 had a 
significant reduction in microfilaria load in just one experiment. 
Immunisation experiments were done just once with recombinant protein, and would 
therefore have to be repeated to confirm the trend observed. On the other hand, two 
independent vaccination studies were done using the synthetic peptides. The trend 
towards reduction in worm / mf burden was inconsistent when both peptides were 
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used. It can therefore not be definitely concluded that vaccination with either 
synthetic peptides or recombinant protein conferred protection to challenge infection. 
Inconsistencies in the protective potential of highly immunogenic filarial proteins have 
been observed before (Peralta et al., 1999). In their study, Peralta and colleagues 
used differential screening with sera of a diverse group of filariasis patients to isolate 
highly immunogenic proteins from a B. malayi expression library. However, 
independent vaccination experiments with the same proteins produced inconsistent 
protection results (Peralta et al., 1999).  
Vaccination with peptide 1 could consistently reduce the microfilaria burden. 
Vaccination with this peptide may interfere with hatching of eggs to microfilaria or the 
development and moulting of microfilaria and L3. Such a hypothesis will be 
consistent with the finding that chitinase is present on the cuticle of post-infective L3 
of unsheathed filarial (Harrison et al., 1999) and on the surface of uterine microfilaria 
(Adam et al., 1996). If chitinase has a role in the the development of filarial worms, 
any process that interferes with enzyme activity could also distort worm development. 
Such a case could be expected by the production of antibodies to the active site of 
the enzyme by vaccination with synthetic peptides. Thus, these molecules may 
therefore have a role in the development of uterine microfilariae and post-infective L3 
which is distorted by vaccination with chitinase. The possible mechanism for 
reduction in microfilaria burden is not clear, and should be understood by 
demonstrating the role of antibodies in the observed tendency towards reduction in 
worm burden. 
3.4 Outlook 
The prospects for the future are three-fold: determination of the biological function of 
A. viteae chitinase, and its possible influence on host physiology; development of 
inhibitors to worm chitinases, and use of different immunisation approaches. 
 
The function of A. viteae chitinase is not well defined. Therefore, future studies would 
be aimed at determining the biological function and possible influence on the host 
physiology. Reverse genetic studies like RNAi would be used to clarify the function of 
this gene in A. viteae. Three chitinase genes were described in this study. Analysis 
demonstrated transcripts in microfilariae, L3 and L4 larvae of A. viteae for gene I 
only, but not for gene III. To verify whether functional transcripts could actually be 
Discussion  53 
produced from gene III, an in vitro transcription / translation system would have to be 
used. In addition, other A. viteae stages will have to be screened for chitinase genes.  
 
Soluble active A. viteae is required for the development of inhibitors to worm 
chitinases, and for crystallisation studies. The expression and purification of soluble 
active chitinase in prokaryotic systems was difficult since most of the protein was 
found in inclusion bodies. The expression of A. viteae chitinase in eukaryotic systems 
like yeast or insect cells would provide better alternatives. Moreover, the proteins will 
be post-synthetically modified in these systems. A comparison of the modification 
pattern with that of native A. viteae chitinase will illustrate the similarities in post-
synthetic modification.  
 
Vaccination with prokaryotically expressed A. viteae chitinase did not lead to 
significant reductions in worm burden. Since, native proteins have been shown to be 
better vaccines in cestodes (Lightowlers et al., 2003), A. viteae chitinase expressed 
in eukaryotic systems would be tested in immunisation experiments along side native 
and prokaryotically expressed A. viteae chitinase.  This will give a clue as to whether 
the modified proteins could have better protective capacities as compared to non-
modified proteins. 
 
4 METHODS 
4.1 Identification of recombinant cDNA and genomic clones from phage 
libraries by plaque hybridisation 
4.1.1 Preparation of plating bacteria 
Host bacteria for bacteriophages (XL 1 blue for lambda zap, and XL 1 blue MRA for 
lambda dash II) were grown overnight at 30°C, 150 rpm in 100 ml LB containing 0.2% 
maltose. Cells were pelleted at 5000 rpm for 10 minutes at 4°C and re-suspended in 
20 ml 10 mM MgSO4 to an OD600 of 2 (about 1.6x109 cells per ml). The cell 
suspension was incubated at 37°C, 220 rpm for 1 hr, stored at 4°C and used for a 
maximum of three days. 
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4.1.2 Plating of lambda phage 
An appropriate volume of phage suspension was mixed with 100 µl (for 88 mm Petri 
dishes) or 200 µl plating bacteria (for 120 mm petri dishes) and incubated with 
shaking (100 rpm) for 15 minutes at 37°C. The suspension was then mixed with 4 or 
8 ml of molten Top agar (50°C) and carefully spread on agar plates. The plates were 
incubated for 30 minutes at room temperature to allow the top agar to harden, and 
were then incubated at 37°C overnight. A uniform bacteria lawn could be observed 
interspersed with lambda plaques. The plates could be stored at 4°C for several 
days. 
4.1.3 Titration of phage libraries 
To determine the concentration of a phage suspension in Plaque Forming Units (pfu) 
per ml, dilutions of a phage stock were made from 1:10 to 1:10, 000 in SM buffer, and 
1 µl of each dilution was plated as described in section 4.1.2. Plates having between 
50 to 350 plaque forming units were used to calculate the phage concentration in pfu. 
4.1.4 Amplification and cryopreservation of phage stocks 
Confluent plates of 3 x 104 pfu/plate were produced and incubated for a maximum of 
8 hours at 37°C. SM buffer was then added to the plates and the plates were 
incubated with constant shaking for 2 hours at 4°C. The lysate was then aspirated 
and centrifuged for 5 minutes at 10, 000 rpm to pellet residual agarose particles and 
the titre was determined as in section 4.1.3. DMSO was then added to 1 ml aliquots 
of bacteriophage stock at a concentration of 7% v/v. The tube was mixed gently, 
plunged into liquid nitrogen and stored at -80°C until used. 
4.2  Screening of libraries 
4.2.1 Screening of libraries with a DIG-labelled A. viteae chitinase probe 
4.2.1.1  Screening of libraries by plaque hybridisation 
Up to 2 x 104 independent plaques were plated on a 120 mm petri dish and cultured 
for 8 to 12 hours. The plates were incubated at 4°Cfor 30 minutes to allow the top 
agar to set. Nylon membranes were rinsed in water and then in 5x SSC and allowed 
to dry at room temperature. The membranes were carefully placed on the surface of 
the infected plate so that the entire membrane was in contact with the plate. After 30 
minutes of incubation at 4°C, the membranes were marked with a hot needle for 
orientation. Plates were again incubated at 4°C for 30 minutes, after which the 
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membranes were removed. Replica filters were also used to lift plaques from infected 
plates. 
DNA on the filters was denatured by incubation with 0.5 M NaOH/ 1.5 M NaCl for 15 
minutes at room temperature, and subsequently neutralised twice by incubation with 
0.5 M Tris, 1.5 M NaCl pH 8.0, after which the filters were allowed to dry on a 
Whatmann filter paper. DNA on the filters was immobilised by covalently linking the 
nucleic acids to the membrane by UV cross-linking. Alternatively, the membranes 
were baked at 80°C for 2 hours. An N-terminal cDNA sequence corresponding to 
nucleotides 52-1,117 of A. viteae L3 chitinase (Adam et al., 1996; Genbank number 
U14638) was labelled with digoxigenin (DIG) using the PCR labelling and detection 
kit from Roche. Hybridisation and detection was done as described by the 
manufacturer (Boehringer, Mannheim). Hybridisation was done with 15 ng/ml of 
probe in 10 ml of hybridisation buffer at a temperature of 50°C overnight. Stringent 
washes were done as follows: membranes were washed for 2 x 15 minutes in ample 
2x SSC, 0.1% SDS at RT, and then in 0.5x SSC, 0.1% SDS (pre-warmed to wash 
temperature) for 2x 30 minutes at 65°C under constant agitation. Chemiluminescent 
detection was done using CSPD (Boehringer Mannheim).  
Agarose plugs containing putatively positive plaques were incubated in SM buffer 
overnight at 4°C to let the phage wander out. The phage suspensions were diluted 
1:10 with H2O and boiled for 5 mins, and 1 µl was used for PCR as in section 
4.3.12.1. Primers were vector-specific (T3 or T7) and A. viteae chitinase-specific. 
To obtain clonal recombinant phages, phage suspensions identified as positive from 
the primary and PCR screening rounds were subjected to three further rounds of 
plaque hybridisation. In order to increase the chances of picking single/ independent 
plaques, 100-fold less independent plaques were used per new screening round as 
the proportion of positive plaques increased.  
4.2.1.2 In vivo excision 
The cDNA libraries used in this study were constructed in the vector Lambda UniZap 
XR (Stratagene). This vector is designed to allow in vivo excision and 
recircularization to form a pBluescript phagemid containing the cloned insert. An 
ExAssist helper phage contains a mutation that prevents replication of the phage 
genome in the non suppressing E. coli host (SOLR) and thus allows only the excised 
phagemid to replicate (Short et al., 1988). In vivo excision was done according to the 
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manufacturer's instructions. Briefly, 5-ml cultures of XL 1 Blue MRF´ and SOLR cells 
were grown at 30°C overnight in LB broth. The cells were pelleted and resuspended 
in 2.5 ml 10 mM MgSO4 to an OD600 of 1.0 (8x108 cells/ml). An excision mix was 
made of 200 µl of XL 1 bLue MRF´ cells, 250 µl phage stock (1x105 phage particles) 
and 1 µl ExAssist helper phage (titer: 1 x107 pfu/ml). The mixture was incubated for 3 
hours at 37°C with shaking. During this period the excision reaction takes place 
leading to the formation of pBluescript phagemid packaged as filamentous particles. 
The tube was heated at 70°C for 20 minutes to lyse the lambda phage particles and 
cells. Following centrifugation (1000xg for 15 minutes), the supernatant containing 
the excised phage particles was then stored. To plate the cells, 100 ul of phage 
supernatant was added to 200 µl SOLR cells (OD600=1) and incubated at 37°C for 15 
minutes. The cells were then plated on LB-ampicillin plates and incubated overnight 
at 37°C. Bacteria colonies were isolated containing the pBluescript double-stranded 
phagemid with the cloned cDNA insert. 
4.3 Purification and manipulation of DNA 
4.3.1 Isolation of lambda DNA and sub-cloning of genomic inserts 
DNA was typically purified from clonal plaques and used for restriction digestion 
analysis, PCR, Southern and subcloning. The genomic libraries used in this study 
were constructed in lambda dash II (Stratagene). This vector, unlike lambda UniZap, 
can not be in vivo excised. To circumvent this short-coming, the inserts were released 
by digestion and cloned into plasmids.  
4.3.1.1 Preparation of crude phage lysates 
Confluent plates of 3 x 104 pfu/plate were produced and incubated for a maximum of 
8 hours at 37°C. SM buffer (10 ml) was then added to the plates and the plates were 
incubated with constant shaking for 2 hours at 4°C. The lysate was aspirated and 
centrifuged for 5 minutes at 10, 000 rpm to pellet agarose particles. 
4.3.1.2 Isolation of phage DNA 
DEAE cellulose columns were prepared and used for isolation of DNA. To prepare 
these columns, hydrochloric acid (0.05N) was slowly added to DE52 powder 
(Whartmann DE52 number 4057-050) with continuous stirring until a pH < 4.5 was 
attained. Concentrated NaOH was then added until the pH was 6.8. The resin was let 
to settle, the supernatant was aspirated and the ion exchanger was then washed 4 to 
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5 times with several volumes of LB-Medium. The slurry was adjusted to 60% resin, 
NaN3 was added to a final concentration of 0.02% and the slurry was stored at 4°C 
for up to three months. Columns were prepared by pouring 8 ml DEAE slurry in a 10-
ml disposable syringe resulting in a bed height of 6 cm. After the DEAE-cellulose had 
settled, the column was washed with 5 ml LB and subsequently equilibrated in LB. 
The supernatant from two plates was loaded onto a 6-8 ml DEAE column. During this 
chromatographic step, bacterial DNA and RNA are separated through ion-exchange 
chromatography; the ion-exchange resin preferentially binds contaminants in the 
lysate such as E. coli DNA, RNA and proteins. The eluate containing the phage 
particles were then collected and pooled. The column was washed again with 2 ml 
LB- Medium and the eluate added to the first. The NaCl concentration of the eluate 
was adjusted to 70 mM and phages were precipitated with 2 volumes of ethanol (20 
minutes at –20°C, and then centrifuged for 15 minutes at 12,000 rpm). The pellet was 
then washed with 2 volumes of 70% ethanol and subsequently dissolved in 2 ml TE 
with 0.2% SDS to release the phage DNA. The mixture was extracted twice with 2 
volumes of Phenol (TE saturated). DNA was precipitated from the aqueous phase 
with 2 volumes of ethanol without any salt. The phage DNA pellet was then washed 
twice with 70% ethanol and dissolved in 200 µl TlowE. The yield was about 75 µg per 
10 ml phage lysate. 
4.3.1.3  Release and sub-cloning of genomic inserts into pBluescript II SK  
Purified recombinant lambda DNA and pBluescript II SK (-) were separately digested 
with Not I and dephosphorylated as described in sections 4.3.8 and 4.3.9. Genomic 
inserts ranging in size between 10-14 kb were then ligated into pBluescript vector 
(3kb) using a 1:1 molar ratio of insert and vector (see section 4.3.10.2). 
4.3.2 Small scale Plasmid isolation from E. coli 
Plasmid DNA was isolated as described by Del Sal et al., 1989, with some slight 
modifications. This technique relies on the property of the detergent cetyl-trimethyl 
ammonium bromide (CTAB) of preferentially precipitating nucleic acids at low NaCl 
concentrations (< 0.6 M), while leaving proteins and polysaccharides in solution.  
 
Essentially, a single bacterial colony harbouring a plasmid of interest was used to 
inoculate 6 ml of LB medium (with an appropriate antibiotic for selection) and grown 
over night at 37°C. Bacterial cells were recovered by centrifugation at 4,000 rpm for 
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10 minutes. The pellet was re-suspended in 200µl of STET buffer, 4µl of a 50-mg/ml 
lysozyme solution was added and the samples were incubated at room temperature 
for 5 minutes. Samples were boiled for 45 seconds and then centrifuged at 13,000 
rpm for 10 minutes in an Eppendorf centrifuge. Pellets were recovered, 5 µl of RNase 
A (10 mg/ml) were added to the supernatants and the samples were incubated for 10 
minutes at 68°C. Nucleic acids were precipitated by the addition of 10 µl of CTAB 
(5% w/v), followed by centrifugation at 14,000 rpm for 5 minutes. Pellets were re-
suspended in 300 µl of 1.2 M NaCl and the plasmids were re-precipitated by the 
addition of 750 µl ethanol and incubation at - 20°C for 1 hour. Samples were then 
centrifuged at 14,000 rpm for 15 minutes and the pellets were washed twice in 70% 
ethanol and allowed to air dry. Plasmids were re-suspended in 40 µl H2O.  The yield 
was between 20 to 40 µg of plasmid DNA. 
4.3.3  Electrophoresis and detection of DNA on agarose gels 
Agarose gel electrophoresis was used for the routine analysis of DNA. Agarose was 
cast in 1x TAE buffer containing 0.5 µg/ml EtBr. The DNA samples (0.1 to 5 µg) were 
dissolved in DNA loading buffer and separated in agarose gels at 10 volts per cm. 
The concentration of the agarose gel was relative to the size of DNA fragments to be 
separated, and was typically between 0.7 and 1.2%. 
4.3.4  Isolation of DNA from agarose gels 
Following electrophoresis, a DNA fragment was excised from agarose gels using a 
clean scalpel, and the DNA was purified using the NucleoSpin® Extraction Kit 
(Clontech) according to the manufacturer's instruction. 
4.3.5 Isolation and concentration of DNA from aqueous solutions 
4.3.5.1  Extraction with Nucleospin kit 
The NucleoSpin DNA Extraction Kit (Clontech) was used according to the 
manufacturer’s instruction for the isolation of DNA from PCR reactions, gel fragments 
and other aqueous DNA solutions. 
4.3.5.2 Phenol chloroform extraction 
To free DNA from protein contaminants, the volume was adjusted to at least 300 µl 
with TE buffer, and extracted with an equal volume of Tris-equilibrated 
phenol:chloroform:isoamyl alcohol (25:24:1) (Sambrook et al., 1989). The aqueous 
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phase was extracted twice with chloroform to remove traces of phenol, and the DNA 
was concentrated by ethanol precipitation.  
 
4.3.5.3 Precipitation of DNA 
Ice cold sodium acetate, pH 4.5 was added to a DNA sample to a final concentration 
of 0.3 M, followed by the addition of 2.5 volumes of ice cold absolute ethanol. The 
sample was incubated at -70°C for 15 minutes and centrifuged at 12, 000 rpm for 15 
minutes at 4°C. The pellet was washed in 70% ethanol, air-dried, and re-suspended 
in an appropriate buffer. 
4.3.6  Isolation of high molecular weight genomic DNA from A. viteae 
About 200 mg to 1 g of adult A. viteae were snap-frozen in liquid nitrogen and ground 
to powder using a mortar and a pestle. Up to 100 mg of powdered worm material was 
suspended in 1.2 ml of digestion buffer containing Proteinase K (100 µg/ml), and 
incubated with shaking at 50°C for 12 to 18 hours until the sample became viscous 
with a visible sludge. The samples were extracted three times with an equal volume 
of phenol/chloroform/isoamyl alcohol. The viscous aqueous phase was transferred 
each time with a wide-bore pipette (0.3-cm-dimeter orifice) into in to a new tube. RNA 
was digested by the addition of 20 µg/ml RNase A and incubating for 1 hour at 37o C. 
Genomic DNA was then precipitated by adding ½ volume of 7.5 M ammonium 
acetate and 2 (original) volumes of 100% ice-cold ethanol. Stringy precipitates of 
DNA were carefully transferred in to new tubes using a blunt spatula, and washed 
twice with ample amounts of 70% ethanol (2 times the original volume). The DNA 
pellet was air dried and re-suspended in TE buffer until dissolved. The concentration 
of the gDNA was determined by photometry and the DNA was analysed on a gel.  
4.3.7 Determination of DNA Concentration 
The concentration of DNA in solution was determined using a spectrophotometer at 
OD260, and subsequently confirmed by comparing the intensity and size of DNA from 
a sample to those of standard size markers with known concentrations. 
 
 1 unit of absorbance of dsDNA at OD260 = 50 µg/ml dsDNA 
 1 unit of absorbance of ssDNA at OD260 = 33 µg/ml ssDNA or RNA 
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The OD280 was also measured and the ratio between the two ODs indicated the 
purity of the DNA solution. For pure DNA, 
 
1.8 ≤ absorbance at OD260 / absorbance at OD280 ≤ 2.0 
 
A value less than 1.8 indicates contamination with proteins or with aromatic 
substances like phenol, while a value greater than 2.0 indicates possible 
contamination with RNA. 
4.3.8 Restriction digestion of DNA 
DNA was digested at the optimal temperature of restriction enzymes according to the 
pipetting scheme below. 
Tab. 12:  Pipetting scheme for restriction digestion of DNA  
Reagent Volume (µl) 
DNA (0.1 – 5 µg) 5  
10 x restriction enzyme buffer 2  
10 x Bovine Serum Albumin (BSA) 2  
Restriction enzyme (3-20 units) 1 
HPLC water 10 
Volume 20 
 
Following digestion, the mixture was either heated at 70°C for 15 minutes to 
inactivate the enzyme, or extracted with phenol chloroform. 
4.3.9 5' Dephosphorylation of digested DNA 
The removal of 5’ phosphate terminals from digested dDNAs ends prevents vector 
self-ligation and reduces background in ligations, especially when only one restriction 
site is used. Shrimp alkaline phosphatase (SAP) (0.5 units) was added to the 
restriction digests and incubated for 15 minutes at 37°C. Enzyme inactivation was 
achieved by heating the mixture at 65°C for 15 minutes. 
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4.3.10 Ligation of DNA fragments 
4.3.10.1  Ligation of PCR fragments into T-overhang vectors 
PCR products were ligated into the pGEM-T vector (Promega, Madison, WI) accord- 
ing to the following protocol. 
The reaction mixture was incubated overnight at 16°C. The ligation reaction was 
used to transform competent bacteria and single clones were picked for the isolation 
of recombinant plasmid DNA that was sequenced and its insert subcloned into an 
appropriate vector where necessary. 
Tab. 13: Pipetting scheme for ligation of PCR fragments into T-overhang vectors 
Reagent Volume (µl) 
Vector (pGEM-T) DNA (50ng) 1  
2X ligation buffer (Promega) 5  
Insert DNA 3  (in three molar excess of the vector) 
T4 DNA ligase 0.5  
HPLC water 0.5  
Reaction volume 10  
 
4.3.10.2 Ligation of DNA fragments with sticky ends 
Insert DNA was digested out of a vector using appropriate restriction enzymes, while 
the target vector was also digested with the same enzymes. Both were then ligated 
following the scheme below. 
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Tab. 14:  Pipetting scheme for ligation of DNA fragments with sticky ends 
Reagent Volume (µl) 
Vector DNA (50ng) 1  
10 x ligation buffer (New England Biolabs) 2 
Insert DNA 3  (in three molar excess of the vector) 
T4 DNA ligase 1  
HPLC water 13  
Reaction volume 20  
 
4.3.11 mRNA isolation, reverse transcription and RT-PCR 
Worms (1g) were homogenised with a plastic pistil in 1000 µl of RNA isolation 
reagent (Peqlab) according to the manufacturer’s instruction, and total RNA was 
isolated by phenol chloroform extraction followed by ethanol washes. Total RNA was 
reverse transcribed by Moloney murine leukemia virus reverse transcriptase 
(Promega) in the presence of random hexamer primers. 
4.3.12 Polymerase chain reaction (PCR) 
Thermostable DNA polymerases were used for the amplification of DNA as described 
(Saiki et al., 1988, Bej et al., 1991). Two types of PCR amplifications were used in 
this study: standard PCR for the amplification of DNA fragments up to 3 kb and Mid-
range PCR for the amplification of fragments up to 9 Kb in size. 
4.3.12.1 Standard PCR 
These were done in 50 µl reaction volumes as shown in Table 15. Optimal annealing 
temperatures for primer pairs relative to a target template were obtained using the 
Oligo 4.0 software. PCR was performed on an MJ Research PT-200 DNA machine 
according to the thermal profile on Table 16. 
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Tab. 15: Pipetting scheme for standard PCR 
Reagent Volume (µl) 
Forward primer (10 pmol/ul) 1  
Reverse primer (10 pmol/ul) 1  
dNTP mix (40 mM) 1  
DNA template   1 – 5 (between 100 to 500 ng) 
10 X reaction buffer 5  
HPLC water ad 50  
Taq polymerase (5 U/ul) 0.5  
Tab. 16:  Thermal profile for standard PCR 
Phase Temperature (°C) Duration  Cycles 
Denaturation 94 2 min 
Annealing 53-60 40 s 
Elongation 72 1 min per 1 kb 
 
1 
Denaturation 94 20 s 
Annealing 53-60 40 s 
Elongation 72 1 min per 1 kb 
 
30 
Denaturation 94 20 s 
Annealing 53-60 40 s 
Elongation 72 15 min 
 4  
 
1 
4.3.12.2 Mid-range PCR 
This PCR technique was used for the amplification of genomic DNA fragments 
between 3 and 9 kb (Barnes et al., 1994; Cheng et al., 1994). These were done using 
the Peq Lab mid-range PCR system as follows: 
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Tab. 17:  Pipetting scheme for Mid range PCR 
Reagent Volume (µl) 
Forward primer (10 pmol/ul) 2  
Reverse primer (10 pmol/ul) 2  
dNTP mix (40 mM) 1.75  
DNA template   1 – 5 (between 100 to 500 ng) 
10 X reaction buffer 5  
HPLC water ad 50  
Mid-range polymerase (5 U/ul) 0.5  
  
PCR was performed on an MJ Research PT-200 DNA machine as follows:  
Tab. 18:  Thermal profile for mid range PCR 
Phase Temperature (°C) Duration  Cycles 
Denaturation 94 2 min 
Annealing 53-60 40 s 
Elongation 68 1 min per 1 kb 
 
1 
Denaturation 94 20 s 
Annealing 53-60 40 s 
Elongation 68 1.5 min per 1 kb 
 
30 
Denaturation 94 20 s 
Annealing 53-60 40 s 
Elongation 68 15 min 
 4  
 
1 
4.4 Southern blotting 
4.4.1 Digestion, electrophoresis, and blotting of genomic DNA 
Genomic DNA (20 µg)  were digested with different restriction enzymes in 100 µl 
reaction volumes as described in section 4.2.7, and electrophoresed in 0.7% agarose 
gels (section 4.2.2). The DNA was capillary-blotted onto a nylon membrane at room 
temperature in 20x SSC overnight (Sambrook et al., 1989). The membrane was then 
baked at 80°C for 2 hours to fix the DNA onto the membrane. 
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4.4.2 Radioactive labeling of A. viteae chitinase probe 
A. viteae chitinase PCR fragments (25 ng) were labelled with 50 µCi α-32 P dCTP 
using the RadPrime DNA labelling system (Life Technologies). The pipetting scheme 
was as follows: 
Tab. 19: Pipetting scheme for radioactive labeling of probes 
Item Volume (µl) 
A. viteae chitinase PCR fragment (25ng) 5  
dATP (500 µM) 1 
dGTP (500µM) 1 
dTTP (500µM) 1 
Random primers solution 20 
α-
32 P dCTP (3000 Ci/mmol, 10mCi/ml) 5 
Distilled water 16 
Klenow fragment 1 
 
The mixture was incubated at 37°C for 10 minutes and the reaction stopped. The 
radioactive probes were purified using SephadexTM MicroSpin G50 columns 
(Amersham Biosciences Europe GmbH). The labelling efficiency was about 30%. 
4.4.3 Hybridisation and detection 
Membranes were washed in 6x SSC at room temperature and prehybridised at 65°C 
in 10 ml hybridisation buffer (6x SSC, 5x Denhardt’s reagent, 0.5% SDS, 100µg/ml 
salmon-sperm DNA) for 1 hour. The probe was denatured by boiling for 2 min in a 
water bath and added to the hybridisation buffer. Membranes were hybridised 
overnight at 65°C in a roller bottle. Stringent washes were done in 2x SSC, 0.5% 
SDS for 5 minutes at room temperature, 2x SSC, 0.1% SDS for 15 minutes at room 
temperature, and 0.1% SSC, 0.1% SDS for 2 hours at 65°C. The membranes were 
rinsed in 0.1x SSC, covered in Saran Wrap, and exposed to a phosphorimager plate 
(Fuji Film) for 3 hours, and the bands were scanned using a phosphoimager. 
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4.5 Microbiological methods 
4.5.1 Preparation of competent E. coli 
Competent E. coli cells were prepared essentially as described by Inoue et al. (1990).  
E. coli were streaked on LB agar plates with antibiotics and cultured overnight at 
37°C. Twelve large colonies were picked with a sterile toothpick and used to 
inoculate 125 ml SOB in a 1-liter Erlenmeyer flask. Flasks were incubated at 18°C 
with vigorous shaking (220 rpm) and the bacteria grown to an OD of 0.6 (mid-log 
phase). Bacteria cultures were poured into Falcon tubes and incubated on ice for 10 
minutes and then centrifuged at 2500x g (3000 rpm) in an Eppendorf 5403 bench top 
centrifuge. The pellet was resuspended in 40 ml ice-cold TB buffer, incubated on ice 
for 10 minutes and centrifuged as above. The pellet was then carefully resuspended 
in 10 ml of TB, and DMSO added drop-wise to a final concentration of 7%. The 
bacterial suspension was incubated for ten minutes on ice, after which 1 ml aliquots 
were snap-frozen in liquid nitrogen and stored at – 80°C for up to one month.  
4.5.2 Transformation of competent E. coli 
Eppendorf tubes (1.5 ml) were pre-chilled on ice and 10 ng of purified plasmid DNA in 
a total volume of 20 µl were pippeted into the tubes. Competent cells were thawed, 
and 200 µl were dispensed into the tubes on ice. The tubes were flicked gently to mix 
and incubated on ice for 30 minutes. The cells were then heat-shocked by heating for 
exactly 45 seconds in a 42°C water bath, and then incubated on ice for 2 minutes. 
Room temperature SOC medium (800 µl) was added to each tube on ice. The tubes 
were then incubated at 37°C while shaking vigorously (220 rpm) for one hour. 
Antibiotic selective agar plates were plated with 50 to 150 µl of the transformation 
mixture and incubated overnight at 37°C. Positive controls were competent cells 
transformed with 10 ng pBluescript SK (-) plasmid, while negative controls were 
competent cells transformed without DNA. 
4.5.3 Screening of bacterial colonies for plasmids/ recombinant plasmids 
Two methods were routinely employed to identify bacteria colonies that contain the 
recombinant plasmids or plasmids of interest. 
4.5.3.1 Blue-white screening 
Most bacteria strains (e.g. JM109,DH5 alpha and XL 1 Blue), used as hosts for initial 
cloning of a target gene, code for  an inactive carboxy-terminal portion of ß-
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galactosidase due to a mutation in the lac Z gene (lacZdeltaM15). On the other hand, 
many vectors contain the regulatory sequences and information that could be 
induced (e.g. by IPTG) to code for the missing amino terminal (alpha region) of the ß-
galactosidase gene. Both host and plasmid encoded fragments are inactive. 
However, if a bacterial host is transformed with a plasmid expressing the missing 
amino terminal of the enzyme, both fragments associate to form an active enzyme in 
a process called alpha complementation. Such bacteria can be recognised because 
they metabolise the chromogenic substrate 5-bromo-4-chloro-3-indolyl-ß-D-
galactoside (X-gal) in the presence of isopropyl-ß-D galactopyranoside (IPTG) to 
form blue colonies. Insertion of a target gene in the alpha peptide region coding for 
the ß-galactosidase enzyme results to insertional inactivation of the alpha peptide. 
Bacteria carrying plasmids with the target gene will form white colonies since they 
lack active ß-galactosidase. Thus, transformed bacteria were plated on LB-agar 
plates supplemented with 0.5 mM IPTG, 80 µg/ml X-gal and antibiotics. 
4.5.3.2 Restriction analysis of isolated plasmids 
In order to verify constructs of plasmids/ inserts resulting from cloning, plasmid DNA 
was isolated and analysed. Independently transformed bacterial colonies were 
picked and grown in 5 ml LB/ antibiotic overnight. Plasmid DNA was isolated (section 
4.3.2) and digested (section 4.3.8) at restriction sites used for cloning of the insert 
DNA. The digested DNA was then analysed by agarose gel electrophoresis (Section 
4.3.3). 
4.5.4 Bacteria cultures and long-term storage of bacterial stocks 
Bacteria host strains used in this study included XL 1 Blue, BL 21 (DE3), and Origami 
B (DE3). Bacteria were streaked on LB agar plates and grown overnight at 37°C. For 
long-term storage of bacteria, a single colony was grown to an OD600 of 0.6 and 1 
part was mixed with 9 parts of Hogness freezing medium (36 mM K2HPO4, 13 mM 
KH2PO4, 20 mM sodium citrate, 10 mM MgSO4 and 40 % glycerol). Tubes with 
bacteria stocks were snap-frozen in liquid nitrogen and stored at -80°C. Bacteria 
recovery involved scraping the surface of a bacteria stock with a sterile loop and 
streaking an LB plate with the appropriate antibiotics. 
4.5.5 Expression and purification of recombinant proteins from E. coli  
The pET expression system was used for prokaryotic expression of recombinant N-
terminal A. viteae chitinase. In this system, target genes are cloned under the control 
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of the T7 promoter which is not recognised by E. coli RNA polymerase. Some E. coli 
host strains (like BL21 (DE3) and Origami B (DE3)) have a chromosomal copy of the 
T7 RNA polymerase gene under control of lacUV5. Transfer of recombinant pET 
plasmids into such hosts results in an IPTG-inducible gene expression system. The 
cDNA encoding the N-terminal domain of chitinase was cloned into the pET 22 b (+) 
vector and transformed into Origami B (DE3 cells). The pET 22 b (+) vector has a 
pelB signal sequence that leads to the localisation of an expressed protein into the 
periplasmatic space of the E. coli host. 
 
A single bacterial colony was picked and used to inoculate LB (100 µg/ml Ampicillin, 
12.5 µg/ml Tetracyclin, 15 µg/ml Kanamycin and 1% glucose) and the culture was 
grown overnight at 37°C, 150 rpm. The overnight culture was diluted 1:50 in fresh LB 
medium and further grown at 37°C till an OD600 of 0.4. The culture was shifted to 
room temperature and further grown to an OD600 of 0.6. Protein expression was 
induced with 1mM IPTG for 4 hours. Bacteria were pelleted by centrifugation at 6000 
rpm for 15 minutes at 4°C. The pellet was then used for the extraction and 
purification of periplasmatic proteins and proteins in inclusion bodies.  
For extraction of periplasmatic fluid, bacteria pellet from a 500 ml culture was 
resuspended in 30 ml 30mM Tris-HCl pH 8, 20% sucrose. EDTA was added to a final 
concentration of 1 mM and the suspension stirred for 10 minutes at room 
temperature. Cells were collected by centrifugation at 10,000xg at 4°C for 10 
minutes. The pellet was then re-suspended in 30 ml of ice-cold 5 mM MgSO4 and 
stirred slowly on ice for 10 minutes to release the periplasmatic proteins. The 
suspension was centrifuged at 10,000xg to pellet the cells and the supernatant was 
used for purification of periplasmatically expressed A. viteae chitinase. The insoluble 
fraction in inclusion bodies was purified as described below. 
The pellet was resuspended in lysis buffer A, 100 ug/ml lysozyme and incubated for 
30 minutes at 4°C. The suspension was then sonicated for 1.5 min, 30 cycles. After 
centrifugation (13,000 rpm, 20 min, 4°C), the supernatant was transferred into a 
falcon  tube, incubated with 1 ml Nickel chelate matrix (Qiagen, Hilden) and 
incubated for 1hr at room temperature with constant gentle shaking. The matrix with 
bound protein was then loaded onto a column and washes were done with 20 ml of 
buffers B and C, respectively. Elution was done in 20 ml of buffer E, and collected in 
1ml fractions. The fractions were analysed by SDS-PAGE for protein and the positive 
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fractions were pooled. This pool was then dialysed in phosphate buffers with 
reducing amounts of urea and the protein concentration was determined. Aliquots of 
the protein were stored at -20°C until used. 
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4.6 Protein analytical methods 
4.6.1 Determination of protein concentration 
Protein concentration was determined by the BCA test using the BCA kit (Pierce, 
Rockford, USA). The basis of this reaction is the biuret reaction: reduction of Cu2+ to 
Cu1+ by a peptide bond under alkaline conditions. Chelation of two molecules of 
bicinchoninic acid (BCA) by the cuprous ion (Cu1+) produces a water soluble 
complex, whose solution has a deep purple colour and an absorbance at 562 nm. A 
linear standard curve was made with 0.05 to 2mg BSA. 
4.6.2 Sodium dodecly sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Analytical polyacrylamide gel electrophoresis in sodium dodecyl sulfate was 
performed as described by Laemmli (1970). Samples were heated for 5 minutes at 
100°C in sample buffer containing 125 mM Tris-HCL, pH 8.3, 1% SDS, 2.5% ß-
mercaptoethanol and 10% glycerol. Samples were applied at volumes of 10-30 µl to 
a 12.5% slab gel cast in a mini-gel apparatus (Hoefer). The electrophoresis was 
performed at 20mA with electrode buffer (25mM Tris-HCL, pH 8.3, 192mM Glycine 
and 0.1% SDS). The run was stopped when the bromophenol blue dye front reached 
the end of the gel. Protein bands were then revealed by staining with Coomassie 
Brilliant Blue R250, and the gels dried for a permanent record.  
4.6.3 Chitinase activity assays 
Chitinase assays were performed using 4-methylumbelliferyl ß-N, N', N’’-
triacetylchitotrioside (GlcNA)3UMB. (GlcNA)3UMB was dissolved in reaction buffer 
(20mM NaPO4, pH 6.0, 200mM NaCl, 1mM EDTA) and 95µl of 20 µM substrate 
solution were mixed with 5µl of enzyme and incubated for 2 to 10 minutes at 25°C. 
The reactions were stopped by adding 1.9 ml of 0.5 M glycine, pH 10.5. Release of 
free methylumbelliferone was measured by a fluorescence spectrophotometer at 360 
nm excitation and 450 nM emission wavelengths. The fluorometer was scaled at the 
beginning of the experiments such that 20 nM substrate had a fluorescence reading 
of 10 units. 
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4.7 Immunochemical and immunological methods 
4.7.1 Western blot 
4.7.1.1 Transfer of proteins onto nitrocellulose membranes 
Proteins separated by SDS-PAGE were immobilised onto nitrocellulose membranes 
by electrophoretic transfers (Towbin et al., 1979). A transfer cassette was assembled 
in transfer buffer using a sponge followed progressively by a 3 MM- Whatmann 
paper, nitrocellulose membrane (pore size 0.2 uM), SDS-PAGE gel, another 
Whatmann paper and finally a second sponge. The cassette was introduced into a 
transfer tank between electrodes so that the gel with the protein was towards the 
negatively charged cathode and the nitrocellulose membrane towards the positively 
charged anode. A constant current of 70 mA was then applied across the cassette at 
room temperature overnight. To determine the transfer efficiency, the membrane was 
reversibly stained in Ponceau S dye (0.1% Ponceau S, 7% trichloroacetic acid in 
distilled water). After complete washing of the Ponceau stain, unbound sites of the 
membrane were blocked by incubation for 45 minutes in 5% skimmed milk powder in 
PBS. 
4.7.1.2 Immunodetection of immobilised proteins 
Nitrocellulose membranes with immobilised proteins were incubated with a primary 
protein specific antibody for one hour at room temperature, followed by 3 x 5 minutes 
washes in wash buffer (PBS, 0.02% Tween 20). The membrane was then incubated 
in a secondary conjugate antibody for one hour followed by washes as above. 
Detection was done by using a substrate for the alkaline phosphatase enzyme 
conjugate, 5-Brom-4-chlor-3-indolylphosphate (BCIP) and tetrazolium chloride (NBT) 
in alkaline phosphatase buffer. All antibodies were diluted in blocking solution (5% 
skimmed milk powder in PBS). 
4.7.2 Coupling of peptides to KLH 
Synthetic peptides (20 amino acids long) were synthesised with two extra N-terminal 
cysteins and coupled to KLH (Keyhole limpet haemocyanin) to make them 
immunogenic. Coupling was done using the Imject maleimide activated mcKLH kit 
(Pierce USA) and the coupled proteins were used at a concentration of 100µg in 
vaccinations. 
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4.7.3 Immunisation studies 
The protective potential of A. viteae N-terminal chitinase was evaluated in the 
Meriones/A. viteae natural host-parasite system. Eight to ten-week-old Meriones 
were anaesthesized with ketamin:xylazin:normal saline (1:1:8) and immunised with 
25 µg recombinant A. viteae chitinase or 100 µg KLH-coupled synthetic A. viteae 
chitinase peptide in adjuvant. The animals were immunised three times in a two-
weekly interval, after which they were challenged with 70 freshly isolated L3s by 
injecting in the neck region. Microfilaria load was verified at weeks 4, 8 and 12 post 
infection (pi), and the animals were dissected at week 12 pi for isolation of adult 
worms and determination of protective potential. 
Two adjuvants were used for immunisation, depending on the immune reaction 
desired: Alum was used for humoral-mediated immune reactions, while STP was 
used for cell-mediated immune responses. 
4.7.3.1 Bleeding of animals for production of sera 
Mice and jirds were bled from the retro-orbital sinus using a microhaematocrit 
capillary, and the blood was stored at 4°C overnight. Blood samples were then 
centrifuged (10,000 rpm, 20 minutes, 25°C) to separate the sera from blot clots. Sera 
were stored in 100 ul aliquots at -20°C.  
4.8 Parasitological methods 
4.8.1 Maintenance of the life cycle of A. viteae 
The life cycle of A. viteae was maintained in Ornithodoros moubata essentially as 
described by Lucius and Textor, 1995. 
4.8.2 Quantification of microfilarial load in blood of jirds 
Infected Meriones were anaesthesized with ketamin:xylazin:normal saline (1:1:8) and 
bled from the retro-orbital sinus using a heparinised glass capillary tube. 20 µl blood 
were mixed with 100µl Teepol (10% in H2O), and the microfilaria load was counted 
using a Fuchs-Rosenthal counting chamber.  
4.8.3 Isolation of filariae 
4.8.3.1 Isolation of adult A. viteae 
Meriones were anaesthetized and fully bled from the retro-orbital sinus. Following 
dissection of the jirds, adult A. viteae were isolated from the subcutaneous and 
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intramuscular tissues, the iunguinal and subscapular regions and some times in the 
thoracic chamber. Animal carcasses were then incubated in normal saline (0.9% 
NaCl) overnight to allow the rest of the worms to wander out. 
4.8.3.2  Isolation of L3 from the vector Ornithodoros moubata 
L3s were isolated using a Baermann apparatus comprising of a funnel with a tap. The 
inner part of the funnel was covered with bandage and filled with Ringer's solution. 
Ticks were cut medially and briefly rinsed in a Petri dish with Ringer’s solution to 
remove rests of blood meal and loose tissue. The ticks were incubated in warm 
Ringer’s solution in the funnels for 1 hr for the L3s to migrate into the solution. The 
tap was then opened to collect the L3s in 50 ml falcon tubes. The larvae were amply 
washed in Ringer's solution and rinsed in RPMI if they were to be used for culture. 
4.8.3.3 Isolation of uterine microfilariae from gravid female worms 
Adult female A. viteae worms were isolated on day 90 post-infection (average length, 
6 cm; embryogenesis starts on day 28 post-infection) and cut into 3mm segments in 
Ringer's solution. Developmental stages were separated from the worm segments by 
filtration. The stages obtained included: oocytes attached to the rachis of the ovary, 
fertilized eggs, multicellular stages, invaginated stages, pretzel and ring stages, and 
elongated microfilariae. 
 
4.9 Computer analysis and statistical methods 
4.9.1 Analysis of DNA sequences 
Genomic DNA sequences obtained from primer walking were assembled into contigs 
by using the program MacVector 7.2 (Accelrys, USA). Assembled sequences were 
fed into Artemis® (www.sanger.ac.uk/Software/Artemis/) for visualisation of sequence 
features, its six-frame translations and exon-intron prediction. Exons thus predicted 
were verified by comparison to a cDNA sequence and by further analysis using 
Netgene (www.cbs.dtu.dk/services/NetGene2/).  Brugia malayi genomic chitinase 
DNA sequences were retrieved from the server for the B. malayi genome project at 
http://www.tigr.org/tdb/e2k1/bma1/ while EST sequence analysis was done at the 
server of the Filaria genome project (http://nema.cap.ed.ac.uk/fgp.html).  
Methods  74 
4.9.2 Statistical analysis 
The worms recovered from immunised and non-immunised Meriones in immunisation 
experiments were compared using the Mann-Whitney U-test at the 95% significance 
level (p<0.05). 
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5 Materials 
5.1 Commercial Kits and Enzymes 
Collagenase A Biochrom, Berlin 
RNase A Boehringer Mannheim, Mannheim 
T4 DNA ligase New England Biolabs, USA 
DNA restriction enzymes New England Biolabs, USA 
Mid-range Polymerase PeqLab, Erlangen 
Sawady Taq Polymerase PeqLab, Erlangen 
Lysosyme Sigma, Deisenhofen 
Qiagen protein purification kit Qiagen, Hilden 
Nucleospin DNA extraction kit Clontech, Heidelberg 
Nucleospin plasmid prep kit Clontech, Heidelberg 
BCA protein assay Kit Pierce, USA 
KLH protein conjugation kit Pierce, USA 
PGEM-TTM Cloning kit Promega, Madison, USA 
Random Primers DNA labeling System Life Technologies, Karlsruhe 
Nick Translation System Life Technologies, Karlsruhe 
5.2 Laboratory Equipment and consumables 
Chromatographic columns Pharmacia, Freiburg 
Agarose gel electrophoresis apparatus AGS, Heidelberg 
SDS-PAGE apparatus Pharmacia, Biotech 
Video documentation apparatus 
E.A.S.Y.RH 
Herolab, Wiesloch 
Peltier Thermal Cycler, PTC-200 MJ-Research, Massachusetts 
Bandelin Sonoplus HD 200 sonicator Berlin 
Spectrophotometer Eppendorf 
DE52 powder ( DE52 number 4057-050) Whatman, USA 
Chromatography paper (3MM) Whatman, USA 
Dialysis membrane Serva, Heidelberg 
Nitrocellulose membrane (0.2 µm) Schleicher & Schuell 
Cell culture plates (Flat & round bottom) Costar, Bodenheim 
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HPLC water Roth, Karlsruhe 
CSPD Boehringer; Mannheim 
5.3 Synthetic oligonuceotides 
Oligogonucleotides were delivered as lyophilised powders and dissolved to final 
concentrations of 100 pmol/µl in water as per manufacturer’s instruction. This stock 
solution was then dissolved 1:10 in water to obtain working solutions with 
concentrations of 10 pmol/ µl. A total of 10 pmol primer was used in standard PCRs, 
while 20 pmol were used in long range PCR. 
5.3.1 PCR Primers 
5.3.1.1 Primers used in long range PCR 
Name Sense Clone Sequence 
T7- long  all GTA ATA CGA CTC ACT ATA GGG C 
T3-long  all AAT TAA CCC TCA CTA AAG GGA AC 
F3 + all CTACGTTCGCGGATGTTAC 
F4 + all TGGGCTTGAAAGTGAGGTAAG 
R4 - all TGTTTGCTCACTTTCAAGCCC 
R7 - 12 TCCCAACTGCCGTGTAAATCA 
R8 - 12 CATTTCCGACAGTAATACGAT 
R5 - 1 CCGGCAGAAATACAATGCTTG 
5.3.1.2 Primers used for standard PCR 
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5.3.2 Sequencing primers 
5.3.2.1 Universal sequencing primers 
5.3.2.1.1 Primers on pGEM-T vector 
Name Sense Sequence 
SP6 - ATTTAG GTG ACA CTA TAG 
T7 + TAA TAC GAC TCA CTA TAG GG 
 
5.3.2.2 Primers on pBluescript SK (-) vector 
Name Sense Position Sequence 
T3 - 772-791 ATTAACCCTCACTAAAGGGA 
T7 + 626-645 TAATACGACTCACTATAGGG 
M13 forward + 603-620 GTA AAACGACGGCCAGT 
M13 reverse - 811-828 CAGGAAACAGCTATGAC 
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5.3.3  Primers used for sequencing A. viteae chitinase genomic clone 1 
Name Sense Position Sequence 
F3      + 5679-5698 CTACGTTCGCGGATGTTAC     
F3walk + 6107-6127 ACACCTATGCACTCACATTC 
F4 + 8698-8719 TGGGCTTGAAAGTGAGGTAAG 
F31 + 8075-8094 TCGCCATCGACAACGAATC 
F5 + 8653-8674 AAGTTGTGGCAAAGGTCCATA 
F6 + 6521-6542 CATCAGTTTTTGCTGTTCGTT          
F7 + 8852-8873 GGACCATACGGAAAAATGATT 
 F7walk + 9208-9229 CAGATAATACTGAAATGCCAG 
R4 - 8698-8709 TGTTTGCTCACTTTCAAGCCC 
R5 - 6025-6046 CCGGCAGAAATACAATGCTTG 
R5walk - 5473-5493 CAATAGATGCTACTCGACAG 
R6 - 4837-4858 GGAATTCAATGAGTTATGCTG 
R6walk - 4280-4301 GACGTATAACACAAAGTACG 
R7 - 7772-7792 TCCCAACTGCCGTGTAAATCA 
M13 forward - vector GTA AAA CGA CGG CCA GT 
R3n1 - 12355-12376 TCAGGCGCTAAGAAAAGAGAG 
R3n1walk - 11550-11573 TAAGGCTCATTTAACTTCGATAT 
R3n2 - 10722-10743 TGGACCATTTCGGGTTTTCTG 
Rur6 - 3706-3727 ATTCTTTGCACCGCNTGTTTC 
Rur6walk - 2948-2968 TAGGTAAAGCGAAAGAGCTG 
Rur6.1 - 2217-2239 GTGAAAATGCGGAAACGGAATA 
Rur6.1walk - 1392-1412 ACTTCCTGAGGCTCTCCCTG 
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5.3.4 Primers used for sequencing A. viteae chitinase genomic clone 9 
Name Sense Position Sequence 
F4 + 6645-6666 TGGGCTTGAAAGTGAGGTAAG 
F>e10_9 + 8187-8208 GGAGAGCCTCAGGAAGTAGTG 
K9_4pups - 9414-9435 ACTAGGAAATTGGGAAAATACAAG 
Rb4_4pupstr + 10265-10286 TGCACTGTCCCATTTATTGTC 
K9_3pup. - 10516-10537 CTTTGTACCGCTTGTTTCTTGTT 
M13 forward + vector GTA AAACGACGGCCA GT 
M13 reverse - vector CAGGAA ACAGCT ATG AC 
K9-FV + 780-801 GGAAATGCAAATACAAACGGC 
K9-RV - 12925-12946 AGGATGTGAGTGCATAGGTG 
K9-V1 - 11359-11380 GTACTTTATCAAACGTACCGT 
K9-V2 - 9973-9993 GAAATAAAATCAGGAAGTTGC 
K9-V3 - 8632-8650 TCAATTCATTTGACTGCCAC 
K9-V4 + 2228-2249 CGAATATTCGTTTATCCATTG 
K9-F1 + 3773-3795 GTAGGAAATGTCACATAACATC 
K9-F2 + 4408-4427 CACTGATCGATGTAATATGC 
K9-F3 + 5227-5240 CTGTGACGATCACTACCAGC 
K9-F4 + 6117-6138 GTGAATAGCAACTTCTTTAGC 
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5.3.5 Primers used for sequencing A. viteae chitinase genomic clone 12 
Name Sense Position Sequence 
    F3      + 1374-1372 CTACGTTCGCGGATGTTAC     
F3.walk12 + 2108-2129 GACGAAGATACCGAATGGTC 
    F4 + 4587-4607 TGGGCTTGAAAGTGAGGTAAG 
    F5 + 4542-4562 AAGTTGTGGCAAAGGTCCATA 
    F5.1 + 5288-5309 TACGTGCATCAAACACAGTC 
    F8 + 4130-4151 TGGCAAGGAAACGGTGGATAA 
    R4 - 4588-4608 TGTTTGCTCACTTTCAAGCCC 
    R7 - 3662-3683 TCCCAACTGCCGTGTAAATCA 
    R8 - 1709-1729 CATTTCCGACAGTAATACGAT 
    R13 -  543-564 AACCACGCTGAAGCCAAAATA 
    R13.1 - 950-971 GTAAGACTTGTACACTTCTG 
    F13 + 5836-5857 GTTTATTTCCGCATCACAGTG 
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5.4 Plasmids 
5.4.1 Cloning plasmids 
5.4.1.1 Cloning plasmid for genomic inserts: pBluescript (Stratagen) 
  
5.4.1.2 TA- overhang vector for cloning PCR products 
 
 
 
Source: Promega 
 
 
5.4.2 Plasmids harbouring genomic and cDNA inserts: λ Dash II and λ Zap, 
respectively 
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Lambda dash II replacement vector map (source: Stratagene) 
 
 
Lambda Uni-Zap XR insertion vector 
 
Expression vector:Vector maps of pET 22 b(+) expression vectors (Novagen) 
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5.5 Buffers and solutions 
5.5.1 Molecular biology 
5.5.1.1 Buffers for separation, purification and storage of DNA 
 
5.5.1.2 Buffers for purification of plasmids: CTAB miniprep 
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5.5.1.3 Buffers for purification of lambda DNA 
 
 
5.5.1.4 Buffers and reagents used for screening of libraries 
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5.5.1.5 Buffers and reagents used for Southern blotting 
 
5.6 Media and buffers for E. coli 
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5.7 Protein and immuno- chemistry  
5.7.1 SDS-PAGE 
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5.7.2 Western blot 
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5.7.3 Buffers for native purification of N-terminal chitinase with Ni2+-NTA 
 
 
5.7.4 Buffers for denaturing purification of N-terminal chitinase with Ni2+-NTA 
 
 
5.7.5 Synthetic peptides 
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5.7.6 Buffers and solutions for chitinase enzyme activity assay 
 
5.7.7 Stock solutions 
 
5.8 Antibiotic stock solutions 
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5.9 E. coli host strains and plasmids 
 
5.10 Databanks, softwares and online services 
Blast server for ESTs: http://www.ebi.ac.uk/blast2/parasites 
Sequence analysis: http://www.ebi.ac.uk/services 
Brugia malayi genome: http://www.tigr.org/tdb/e2k1/bma1/ 
Filaria genome Project: http://nema.cap.ed.ac.uk/fgp.html 
5.11 Softwares 
Genomic DNA analysis, Artemis: www.sanger.ac.uk/Software/Artemis/ 
Clustalw: http://www.ebi.ac.uk/clustalw/ 
Netgene: www.cbs.dtu.dk/services/NetGene2/ 
MacVector 7.2: Accelrys, USA 
Oligo 4.0:http://www.oligo.net/ 
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6 Abbreviations 
APS Ammonium peroxidisulfate 
A Adenosine 
APOC African Programme for Onchocerciasis Control 
Amp Ampicillin 
AP Alkaline phosphatase 
bp Base pairs 
BCA 2,2´Bicinchoninic acid 
BCIP 5-Bromo-4-chloro-3-indolyphosphate disodium salt 
BSA Bovine serum albumin (Fraction V) 
cDNA Complementary DNA 
CTAB Cetyltrimethylamoniumbromide 
DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleoside triphosphate 
DTT Dithiothreitol 
EDTA Ethylenediamino tetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
EtBr Ethidium bromide 
EtOH Ethanol 
HPLC High performance liquid chromatography 
IPTG Isopropyl-thio-ß-D-galactopyranoside 
IU International unit 
kb Kilo base 
L1 First stage larvae 
L2 Second stage larvae 
L3 Third stage larvae 
L4 Fourth stage larvae 
LB Lauria Bertani 
LM Low melting 
2-ME ß-Mercaptoethanol 
mAb Monoclonal antibody 
Mf Microfilariae 
mRNA Messenger RNA 
NBT Nitroblue tetrazoliumchloride 
NC Nitrocellulose 
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OCP Onchocerciasis Control Program 
OD Optical density 
ON Overnight 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEG Polyethyleneglycol 
PIPES 1,4-Piperazinediethane sulfonic acid 
PMSF Phenylmethylsuöphonylflouride 
RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
RT Room temperature 
SDS Sodium dodecylsulfate 
TAE Tris-acetate-EDTA 
TB Transformation buffer 
TBS Tris-buffered saline 
TE Tris-EDTA 
TEMED N,N,N’,N’-Tetramethylethylenediamine 
TRIS 2-Amino-2-hydroxymethyl-1,3-propandiol 
U Units 
UV Ultraviolet 
X-gal 5-Bromo-4-chloro-3-indoxyl-ß-D-galactoside 
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Appendix 2: Insert of Clone 9; Sequence Range: 1 to 13753  
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Appendix 3: Partial insert of clone 12. Sequence Range: 1 to 6506 
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Appendix 4: Consecutive alignment of exon L (Gene I) to exon Z (Gene III) 
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Appendix 5: Arguments for differences and similarities in gene sequences of 
clone 1 and 9 
 
1) Identities in intergenic region between clones= 97 (Differences below) 
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2) Introns and Exons of identical regions of clones 1 and 9 showing discrepancies 
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